Project
avrg: Epithelial-Mesenchymal Transition, human (Scheel, 2011)
Navigation
Downloads
Results for ZEB1
Z-value: 18.32
Motif logo
Transcription factors associated with ZEB1
| Gene Symbol | Gene ID | Gene Info |
|---|---|---|
|
ZEB1
|
ENSG00000148516.23 | zinc finger E-box binding homeobox 1 |
Activity-expression correlation:
| Gene | Promoter | Pearson corr. coef. | P-value | Plot |
|---|---|---|---|---|
| ZEB1 | hg38_v1_chr10_+_31319125_31319227 | -0.99 | 1.5e-06 | Click! |
Activity profile of ZEB1 motif
Sorted Z-values of ZEB1 motif
Network of associatons between targets according to the STRING database.
First level regulatory network of ZEB1
Gene Ontology Analysis
Gene overrepresentation in biological process category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 23.4 | 140.2 | GO:1904274 | tricellular tight junction assembly(GO:1904274) |
| 12.3 | 49.1 | GO:0060671 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
| 12.1 | 36.2 | GO:0048817 | negative regulation of hair follicle maturation(GO:0048817) |
| 7.8 | 54.5 | GO:0010482 | epidermal cell division(GO:0010481) regulation of epidermal cell division(GO:0010482) |
| 6.5 | 26.2 | GO:0032600 | B cell receptor transport within lipid bilayer(GO:0032595) B cell receptor transport into membrane raft(GO:0032597) protein transport out of membrane raft(GO:0032599) chemokine receptor transport out of membrane raft(GO:0032600) negative regulation of transforming growth factor beta3 production(GO:0032913) chemokine receptor transport within lipid bilayer(GO:0033606) |
| 6.0 | 24.0 | GO:0002159 | desmosome assembly(GO:0002159) |
| 5.3 | 26.5 | GO:0061146 | Peyer's patch morphogenesis(GO:0061146) lymphocyte migration into lymphoid organs(GO:0097021) |
| 4.9 | 39.1 | GO:0086042 | cardiac muscle cell-cardiac muscle cell adhesion(GO:0086042) |
| 4.8 | 14.3 | GO:0048560 | establishment of anatomical structure orientation(GO:0048560) |
| 4.3 | 13.0 | GO:1900220 | semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis(GO:1900220) |
| 3.7 | 11.2 | GO:0042231 | interleukin-13 biosynthetic process(GO:0042231) |
| 3.5 | 13.9 | GO:0071226 | response to molecule of fungal origin(GO:0002238) positive regulation of interleukin-3 production(GO:0032752) interleukin-3 biosynthetic process(GO:0042223) regulation of interleukin-3 biosynthetic process(GO:0045399) positive regulation of interleukin-3 biosynthetic process(GO:0045401) cellular response to molecule of fungal origin(GO:0071226) |
| 3.5 | 13.8 | GO:1903575 | cornified envelope assembly(GO:1903575) |
| 3.1 | 12.4 | GO:0010980 | regulation of vitamin D 24-hydroxylase activity(GO:0010979) positive regulation of vitamin D 24-hydroxylase activity(GO:0010980) |
| 3.1 | 18.4 | GO:0061502 | early endosome to recycling endosome transport(GO:0061502) |
| 2.9 | 8.8 | GO:0002582 | positive regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002582) positive regulation of antigen processing and presentation of peptide antigen(GO:0002585) positive regulation of antigen processing and presentation of peptide antigen via MHC class II(GO:0002588) |
| 2.9 | 8.6 | GO:0043000 | Golgi to plasma membrane CFTR protein transport(GO:0043000) |
| 2.7 | 10.7 | GO:0038018 | Wnt receptor catabolic process(GO:0038018) |
| 2.7 | 16.0 | GO:1904209 | regulation of chemokine (C-C motif) ligand 2 secretion(GO:1904207) positive regulation of chemokine (C-C motif) ligand 2 secretion(GO:1904209) |
| 2.6 | 15.6 | GO:0045218 | zonula adherens maintenance(GO:0045218) |
| 2.6 | 7.7 | GO:1901993 | meiotic cell cycle phase transition(GO:0044771) regulation of meiotic cell cycle phase transition(GO:1901993) negative regulation of meiotic cell cycle phase transition(GO:1901994) |
| 2.5 | 29.5 | GO:0070863 | positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
| 2.3 | 7.0 | GO:0009720 | detection of hormone stimulus(GO:0009720) |
| 2.3 | 11.4 | GO:0071109 | superior temporal gyrus development(GO:0071109) |
| 2.2 | 24.7 | GO:0019368 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
| 2.1 | 10.5 | GO:0090611 | ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway(GO:0090611) |
| 2.1 | 6.3 | GO:0051040 | regulation of calcium-independent cell-cell adhesion(GO:0051040) |
| 2.1 | 6.2 | GO:0051142 | regulation of NK T cell proliferation(GO:0051140) positive regulation of NK T cell proliferation(GO:0051142) |
| 2.1 | 57.4 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
| 2.0 | 10.2 | GO:2000721 | positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000721) |
| 2.0 | 18.2 | GO:0001661 | conditioned taste aversion(GO:0001661) |
| 1.9 | 7.4 | GO:0048627 | myoblast development(GO:0048627) |
| 1.9 | 5.6 | GO:0060086 | circadian temperature homeostasis(GO:0060086) |
| 1.9 | 7.4 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
| 1.8 | 5.5 | GO:0097534 | lymphoid lineage cell migration(GO:0097534) lymphoid lineage cell migration into thymus(GO:0097535) |
| 1.8 | 28.9 | GO:0021796 | cerebral cortex regionalization(GO:0021796) |
| 1.8 | 16.1 | GO:0042492 | gamma-delta T cell differentiation(GO:0042492) |
| 1.8 | 8.9 | GO:1902941 | regulation of voltage-gated chloride channel activity(GO:1902941) positive regulation of voltage-gated chloride channel activity(GO:1902943) |
| 1.8 | 1.8 | GO:0061763 | multivesicular body-lysosome fusion(GO:0061763) |
| 1.8 | 12.4 | GO:0032439 | endosome localization(GO:0032439) |
| 1.7 | 18.6 | GO:1902414 | protein localization to cell junction(GO:1902414) |
| 1.7 | 8.4 | GO:0044752 | response to human chorionic gonadotropin(GO:0044752) |
| 1.7 | 5.0 | GO:0090271 | positive regulation of fibroblast growth factor production(GO:0090271) |
| 1.6 | 8.2 | GO:2001181 | positive regulation of interleukin-10 secretion(GO:2001181) |
| 1.6 | 4.9 | GO:0060003 | copper ion export(GO:0060003) |
| 1.6 | 8.2 | GO:0034343 | type III interferon production(GO:0034343) regulation of type III interferon production(GO:0034344) |
| 1.6 | 26.0 | GO:1900029 | positive regulation of ruffle assembly(GO:1900029) |
| 1.6 | 3.2 | GO:0002586 | regulation of antigen processing and presentation of peptide antigen via MHC class II(GO:0002586) |
| 1.6 | 14.4 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
| 1.6 | 4.7 | GO:0061163 | endoplasmic reticulum polarization(GO:0061163) actin filament bundle retrograde transport(GO:0061573) actin filament bundle distribution(GO:0070650) |
| 1.6 | 14.1 | GO:0070673 | response to interleukin-18(GO:0070673) |
| 1.6 | 40.6 | GO:0090026 | positive regulation of monocyte chemotaxis(GO:0090026) |
| 1.5 | 6.2 | GO:0060268 | negative regulation of respiratory burst(GO:0060268) |
| 1.5 | 23.0 | GO:0031642 | negative regulation of myelination(GO:0031642) |
| 1.5 | 7.7 | GO:0008078 | mesodermal cell migration(GO:0008078) |
| 1.5 | 4.6 | GO:0061589 | calcium activated phosphatidylserine scrambling(GO:0061589) |
| 1.5 | 4.5 | GO:0045013 | carbon catabolite repression of transcription(GO:0045013) negative regulation of transcription by glucose(GO:0045014) |
| 1.5 | 6.0 | GO:0072660 | maintenance of protein location in membrane(GO:0072658) maintenance of protein location in plasma membrane(GO:0072660) positive regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900827) |
| 1.5 | 19.4 | GO:0038129 | ERBB3 signaling pathway(GO:0038129) |
| 1.5 | 1.5 | GO:0060031 | mediolateral intercalation(GO:0060031) planar cell polarity pathway involved in gastrula mediolateral intercalation(GO:0060775) |
| 1.5 | 5.9 | GO:2000569 | T-helper 2 cell activation(GO:0035712) regulation of T-helper 2 cell activation(GO:2000569) positive regulation of T-helper 2 cell activation(GO:2000570) |
| 1.5 | 16.1 | GO:0071681 | response to indole-3-methanol(GO:0071680) cellular response to indole-3-methanol(GO:0071681) |
| 1.5 | 4.4 | GO:1990654 | regulation of extrathymic T cell differentiation(GO:0033082) sebum secreting cell proliferation(GO:1990654) |
| 1.5 | 8.8 | GO:0002803 | positive regulation of antimicrobial peptide production(GO:0002225) positive regulation of antibacterial peptide production(GO:0002803) |
| 1.4 | 15.0 | GO:0006657 | CDP-choline pathway(GO:0006657) |
| 1.4 | 5.4 | GO:0003104 | positive regulation of glomerular filtration(GO:0003104) |
| 1.3 | 6.6 | GO:0009137 | purine nucleoside diphosphate catabolic process(GO:0009137) purine ribonucleoside diphosphate catabolic process(GO:0009181) |
| 1.3 | 11.9 | GO:0042695 | thelarche(GO:0042695) mammary gland branching involved in thelarche(GO:0060744) epithelial cell proliferation involved in mammary gland duct elongation(GO:0060750) |
| 1.3 | 24.4 | GO:0009950 | dorsal/ventral axis specification(GO:0009950) |
| 1.3 | 5.1 | GO:0000738 | DNA catabolic process, exonucleolytic(GO:0000738) |
| 1.3 | 29.2 | GO:0051639 | actin filament network formation(GO:0051639) |
| 1.3 | 5.1 | GO:0035606 | peptidyl-cysteine S-trans-nitrosylation(GO:0035606) |
| 1.3 | 21.4 | GO:0015871 | choline transport(GO:0015871) |
| 1.2 | 12.2 | GO:0098967 | exocytic insertion of neurotransmitter receptor to plasma membrane(GO:0098881) exocytic insertion of neurotransmitter receptor to postsynaptic membrane(GO:0098967) |
| 1.2 | 9.7 | GO:0045607 | regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
| 1.2 | 6.1 | GO:0021999 | neural plate anterior/posterior regionalization(GO:0021999) neural plate regionalization(GO:0060897) |
| 1.2 | 7.2 | GO:0060214 | endocardium formation(GO:0060214) |
| 1.2 | 3.6 | GO:0071469 | detection of mechanical stimulus involved in sensory perception of touch(GO:0050976) cellular response to alkaline pH(GO:0071469) |
| 1.2 | 5.9 | GO:0006015 | 5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
| 1.2 | 1.2 | GO:0072003 | kidney rudiment formation(GO:0072003) |
| 1.2 | 2.3 | GO:1904398 | positive regulation of neuromuscular junction development(GO:1904398) |
| 1.1 | 3.4 | GO:0003241 | growth involved in heart morphogenesis(GO:0003241) cardiac muscle tissue growth involved in heart morphogenesis(GO:0003245) |
| 1.1 | 3.4 | GO:0072192 | BMP signaling pathway involved in heart induction(GO:0003130) endodermal-mesodermal cell signaling(GO:0003133) endodermal-mesodermal cell signaling involved in heart induction(GO:0003134) apoptotic process involved in endocardial cushion morphogenesis(GO:0003277) cell-cell signaling involved in cell fate commitment(GO:0045168) intermediate mesoderm morphogenesis(GO:0048390) intermediate mesoderm formation(GO:0048391) intermediate mesodermal cell differentiation(GO:0048392) regulation of cardiac muscle fiber development(GO:0055018) positive regulation of cardiac muscle fiber development(GO:0055020) bud dilation involved in lung branching(GO:0060503) BMP signaling pathway involved in ureter morphogenesis(GO:0061149) renal system segmentation(GO:0061150) BMP signaling pathway involved in renal system segmentation(GO:0061151) pulmonary artery endothelial tube morphogenesis(GO:0061155) regulation of transcription from RNA polymerase II promoter involved in mesonephros development(GO:0061216) BMP signaling pathway involved in nephric duct formation(GO:0071893) negative regulation of branch elongation involved in ureteric bud branching(GO:0072096) negative regulation of branch elongation involved in ureteric bud branching by BMP signaling pathway(GO:0072097) anterior/posterior pattern specification involved in ureteric bud development(GO:0072099) specification of ureteric bud anterior/posterior symmetry(GO:0072100) specification of ureteric bud anterior/posterior symmetry by BMP signaling pathway(GO:0072101) ureter epithelial cell differentiation(GO:0072192) negative regulation of mesenchymal cell proliferation involved in ureter development(GO:0072200) regulation of cell proliferation involved in outflow tract morphogenesis(GO:1901963) positive regulation of cell proliferation involved in outflow tract morphogenesis(GO:1901964) cardiac jelly development(GO:1905072) regulation of metanephric S-shaped body morphogenesis(GO:2000004) negative regulation of metanephric S-shaped body morphogenesis(GO:2000005) regulation of metanephric comma-shaped body morphogenesis(GO:2000006) negative regulation of metanephric comma-shaped body morphogenesis(GO:2000007) |
| 1.1 | 4.5 | GO:0032690 | negative regulation of interleukin-1 alpha production(GO:0032690) negative regulation of interleukin-1 alpha secretion(GO:0050712) |
| 1.1 | 3.3 | GO:0002408 | myeloid dendritic cell chemotaxis(GO:0002408) |
| 1.1 | 98.2 | GO:0070830 | bicellular tight junction assembly(GO:0070830) |
| 1.1 | 4.4 | GO:0016256 | N-glycan processing to lysosome(GO:0016256) |
| 1.1 | 5.5 | GO:1904217 | regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
| 1.1 | 3.2 | GO:1904899 | regulation of hepatic stellate cell proliferation(GO:1904897) positive regulation of hepatic stellate cell proliferation(GO:1904899) hepatic stellate cell proliferation(GO:1990922) |
| 1.1 | 16.0 | GO:0034983 | peptidyl-lysine deacetylation(GO:0034983) |
| 1.1 | 5.3 | GO:0060480 | lung goblet cell differentiation(GO:0060480) |
| 1.1 | 4.3 | GO:2000660 | negative regulation of interleukin-1-mediated signaling pathway(GO:2000660) |
| 1.1 | 8.4 | GO:0007185 | transmembrane receptor protein tyrosine phosphatase signaling pathway(GO:0007185) |
| 1.1 | 4.2 | GO:0015766 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
| 1.0 | 12.6 | GO:2001288 | positive regulation of caveolin-mediated endocytosis(GO:2001288) |
| 1.0 | 2.1 | GO:0014916 | regulation of lung blood pressure(GO:0014916) |
| 1.0 | 7.2 | GO:0036486 | trunk segmentation(GO:0035290) trunk neural crest cell migration(GO:0036484) ventral trunk neural crest cell migration(GO:0036486) |
| 1.0 | 2.0 | GO:0051885 | positive regulation of anagen(GO:0051885) |
| 1.0 | 3.0 | GO:0016108 | tetraterpenoid metabolic process(GO:0016108) carotenoid metabolic process(GO:0016116) carotene catabolic process(GO:0016121) xanthophyll metabolic process(GO:0016122) terpene catabolic process(GO:0046247) |
| 1.0 | 7.0 | GO:0015888 | thiamine transport(GO:0015888) |
| 1.0 | 2.9 | GO:0002528 | regulation of vascular permeability involved in acute inflammatory response(GO:0002528) |
| 1.0 | 3.9 | GO:0030200 | heparan sulfate proteoglycan catabolic process(GO:0030200) |
| 1.0 | 5.8 | GO:0033277 | abortive mitotic cell cycle(GO:0033277) |
| 1.0 | 1.0 | GO:1903921 | protein processing in phagocytic vesicle(GO:1900756) regulation of protein processing in phagocytic vesicle(GO:1903921) positive regulation of protein processing in phagocytic vesicle(GO:1903923) |
| 1.0 | 3.8 | GO:0002541 | activation of plasma proteins involved in acute inflammatory response(GO:0002541) |
| 0.9 | 14.1 | GO:0060670 | branching involved in labyrinthine layer morphogenesis(GO:0060670) |
| 0.9 | 5.6 | GO:1903588 | negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:1903588) |
| 0.9 | 15.8 | GO:0045741 | positive regulation of epidermal growth factor-activated receptor activity(GO:0045741) |
| 0.9 | 27.3 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
| 0.9 | 5.5 | GO:0098902 | regulation of membrane depolarization during action potential(GO:0098902) |
| 0.9 | 0.9 | GO:0002786 | regulation of antimicrobial peptide production(GO:0002784) regulation of antibacterial peptide production(GO:0002786) |
| 0.9 | 2.7 | GO:0002025 | vasodilation by norepinephrine-epinephrine involved in regulation of systemic arterial blood pressure(GO:0002025) |
| 0.9 | 3.5 | GO:0035627 | ceramide transport(GO:0035627) |
| 0.9 | 10.6 | GO:0021800 | cerebral cortex tangential migration(GO:0021800) |
| 0.9 | 5.2 | GO:1903237 | negative regulation of leukocyte tethering or rolling(GO:1903237) |
| 0.9 | 12.1 | GO:0032119 | sequestering of zinc ion(GO:0032119) |
| 0.9 | 4.3 | GO:0060282 | positive regulation of oocyte development(GO:0060282) |
| 0.9 | 4.3 | GO:0030035 | microspike assembly(GO:0030035) |
| 0.8 | 3.4 | GO:0010609 | mRNA localization resulting in posttranscriptional regulation of gene expression(GO:0010609) |
| 0.8 | 5.9 | GO:0051673 | membrane disruption in other organism(GO:0051673) |
| 0.8 | 4.1 | GO:0018243 | protein O-linked glycosylation via threonine(GO:0018243) |
| 0.8 | 0.8 | GO:0016119 | carotene metabolic process(GO:0016119) |
| 0.8 | 3.3 | GO:0060484 | lung-associated mesenchyme development(GO:0060484) |
| 0.8 | 10.6 | GO:0070327 | thyroid hormone transport(GO:0070327) |
| 0.8 | 2.4 | GO:0060738 | epithelial-mesenchymal signaling involved in prostate gland development(GO:0060738) |
| 0.8 | 3.2 | GO:0033693 | neurofilament bundle assembly(GO:0033693) |
| 0.8 | 3.9 | GO:0071955 | recycling endosome to Golgi transport(GO:0071955) |
| 0.8 | 3.9 | GO:0002317 | plasma cell differentiation(GO:0002317) |
| 0.8 | 2.3 | GO:0060739 | mesenchymal-epithelial cell signaling involved in prostate gland development(GO:0060739) |
| 0.8 | 6.2 | GO:0015760 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
| 0.8 | 2.3 | GO:1903028 | positive regulation of opsonization(GO:1903028) |
| 0.8 | 9.2 | GO:0051599 | response to hydrostatic pressure(GO:0051599) |
| 0.8 | 12.3 | GO:0006670 | sphingosine metabolic process(GO:0006670) |
| 0.8 | 2.3 | GO:0016103 | diterpenoid catabolic process(GO:0016103) retinoic acid catabolic process(GO:0034653) |
| 0.8 | 3.0 | GO:0042335 | cuticle development(GO:0042335) |
| 0.7 | 2.2 | GO:0000103 | sulfate assimilation(GO:0000103) |
| 0.7 | 3.7 | GO:1903412 | response to bile acid(GO:1903412) |
| 0.7 | 2.2 | GO:0038195 | urokinase plasminogen activator signaling pathway(GO:0038195) |
| 0.7 | 2.9 | GO:0045658 | regulation of neutrophil differentiation(GO:0045658) negative regulation of neutrophil differentiation(GO:0045659) |
| 0.7 | 3.6 | GO:0060373 | regulation of ventricular cardiac muscle cell membrane depolarization(GO:0060373) |
| 0.7 | 8.4 | GO:0032782 | bile acid secretion(GO:0032782) |
| 0.7 | 2.8 | GO:0003430 | growth plate cartilage chondrocyte growth(GO:0003430) |
| 0.7 | 2.1 | GO:0071072 | negative regulation of phospholipid biosynthetic process(GO:0071072) |
| 0.7 | 7.5 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
| 0.7 | 3.4 | GO:2000553 | positive regulation of T-helper 2 cell cytokine production(GO:2000553) |
| 0.7 | 1.3 | GO:1902499 | positive regulation of protein autoubiquitination(GO:1902499) |
| 0.7 | 2.6 | GO:0010587 | miRNA catabolic process(GO:0010587) |
| 0.7 | 2.0 | GO:0008358 | oocyte construction(GO:0007308) oocyte axis specification(GO:0007309) oocyte anterior/posterior axis specification(GO:0007314) pole plasm assembly(GO:0007315) maternal determination of anterior/posterior axis, embryo(GO:0008358) P granule organization(GO:0030719) |
| 0.6 | 2.6 | GO:0061091 | regulation of phospholipid translocation(GO:0061091) positive regulation of phospholipid translocation(GO:0061092) |
| 0.6 | 0.6 | GO:1904862 | inhibitory synapse assembly(GO:1904862) |
| 0.6 | 11.8 | GO:0070886 | positive regulation of calcineurin-NFAT signaling cascade(GO:0070886) |
| 0.6 | 3.1 | GO:0002545 | chronic inflammatory response to non-antigenic stimulus(GO:0002545) regulation of chronic inflammatory response to non-antigenic stimulus(GO:0002880) |
| 0.6 | 3.1 | GO:0050915 | sensory perception of sour taste(GO:0050915) |
| 0.6 | 102.6 | GO:0008543 | fibroblast growth factor receptor signaling pathway(GO:0008543) |
| 0.6 | 3.6 | GO:0031133 | regulation of axon diameter(GO:0031133) |
| 0.6 | 1.8 | GO:1904823 | pyrimidine nucleobase transport(GO:0015855) purine nucleobase transmembrane transport(GO:1904823) |
| 0.6 | 2.4 | GO:2000138 | positive regulation of cell proliferation involved in heart morphogenesis(GO:2000138) |
| 0.6 | 8.9 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
| 0.6 | 1.2 | GO:0060481 | lobar bronchus epithelium development(GO:0060481) |
| 0.6 | 31.2 | GO:0051602 | response to electrical stimulus(GO:0051602) |
| 0.6 | 14.7 | GO:2000251 | positive regulation of actin cytoskeleton reorganization(GO:2000251) |
| 0.6 | 3.5 | GO:0006196 | AMP catabolic process(GO:0006196) |
| 0.6 | 1.8 | GO:0002949 | tRNA threonylcarbamoyladenosine modification(GO:0002949) |
| 0.6 | 5.2 | GO:0051122 | hepoxilin metabolic process(GO:0051121) hepoxilin biosynthetic process(GO:0051122) |
| 0.6 | 1.7 | GO:0018057 | peptidyl-lysine oxidation(GO:0018057) negative regulation of T-helper 17 cell lineage commitment(GO:2000329) |
| 0.6 | 1.2 | GO:0006659 | phosphatidylserine biosynthetic process(GO:0006659) |
| 0.6 | 1.2 | GO:1902202 | regulation of hepatocyte growth factor receptor signaling pathway(GO:1902202) |
| 0.6 | 1.7 | GO:1904580 | regulation of intracellular mRNA localization(GO:1904580) positive regulation of intracellular mRNA localization(GO:1904582) |
| 0.6 | 2.2 | GO:0010046 | response to mycotoxin(GO:0010046) |
| 0.6 | 18.9 | GO:0043616 | keratinocyte proliferation(GO:0043616) |
| 0.6 | 2.8 | GO:1902081 | regulation of calcium ion import into sarcoplasmic reticulum(GO:1902080) negative regulation of calcium ion import into sarcoplasmic reticulum(GO:1902081) |
| 0.6 | 4.4 | GO:0034773 | histone H4-K20 trimethylation(GO:0034773) |
| 0.5 | 1.6 | GO:0032826 | natural killer cell differentiation involved in immune response(GO:0002325) negative regulation of natural killer cell differentiation(GO:0032824) regulation of natural killer cell differentiation involved in immune response(GO:0032826) negative regulation of natural killer cell differentiation involved in immune response(GO:0032827) |
| 0.5 | 5.9 | GO:1904352 | positive regulation of protein catabolic process in the vacuole(GO:1904352) |
| 0.5 | 3.2 | GO:1903385 | regulation of homophilic cell adhesion(GO:1903385) |
| 0.5 | 4.3 | GO:0015811 | L-cystine transport(GO:0015811) |
| 0.5 | 4.3 | GO:0002329 | pre-B cell differentiation(GO:0002329) |
| 0.5 | 2.7 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
| 0.5 | 2.1 | GO:0009257 | 10-formyltetrahydrofolate biosynthetic process(GO:0009257) |
| 0.5 | 5.3 | GO:0007028 | cytoplasm organization(GO:0007028) |
| 0.5 | 2.1 | GO:0061073 | ciliary body morphogenesis(GO:0061073) |
| 0.5 | 5.7 | GO:1900623 | regulation of monocyte aggregation(GO:1900623) positive regulation of monocyte aggregation(GO:1900625) |
| 0.5 | 4.6 | GO:0035726 | common myeloid progenitor cell proliferation(GO:0035726) |
| 0.5 | 4.1 | GO:0060005 | vestibular reflex(GO:0060005) |
| 0.5 | 6.6 | GO:1902902 | negative regulation of autophagosome assembly(GO:1902902) |
| 0.5 | 8.1 | GO:0035269 | protein O-linked mannosylation(GO:0035269) |
| 0.5 | 36.4 | GO:2000649 | regulation of sodium ion transmembrane transporter activity(GO:2000649) |
| 0.5 | 3.0 | GO:0032911 | negative regulation of transforming growth factor beta1 production(GO:0032911) |
| 0.5 | 1.5 | GO:0006478 | peptidyl-tyrosine sulfation(GO:0006478) |
| 0.5 | 21.0 | GO:0045022 | early endosome to late endosome transport(GO:0045022) vesicle-mediated transport between endosomal compartments(GO:0098927) |
| 0.5 | 2.0 | GO:0044210 | 'de novo' CTP biosynthetic process(GO:0044210) |
| 0.5 | 7.3 | GO:0038203 | TORC2 signaling(GO:0038203) |
| 0.5 | 1.4 | GO:0006421 | asparaginyl-tRNA aminoacylation(GO:0006421) |
| 0.5 | 1.4 | GO:0031508 | pericentric heterochromatin assembly(GO:0031508) |
| 0.5 | 1.4 | GO:0002184 | cytoplasmic translational termination(GO:0002184) |
| 0.5 | 1.4 | GO:0060903 | positive regulation of meiosis I(GO:0060903) |
| 0.5 | 1.8 | GO:1903381 | neuron intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress(GO:0036483) regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903381) negative regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903382) |
| 0.5 | 0.9 | GO:0021558 | trochlear nerve development(GO:0021558) |
| 0.4 | 2.7 | GO:0021633 | optic nerve structural organization(GO:0021633) |
| 0.4 | 7.6 | GO:0016540 | protein autoprocessing(GO:0016540) |
| 0.4 | 6.1 | GO:0090179 | planar cell polarity pathway involved in neural tube closure(GO:0090179) |
| 0.4 | 5.2 | GO:2000786 | positive regulation of autophagosome assembly(GO:2000786) |
| 0.4 | 2.6 | GO:0030311 | poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
| 0.4 | 3.0 | GO:1904749 | regulation of protein localization to nucleolus(GO:1904749) |
| 0.4 | 1.3 | GO:0099538 | synaptic signaling via neuropeptide(GO:0099538) trans-synaptic signaling by neuropeptide(GO:0099540) trans-synaptic signaling by neuropeptide, modulating synaptic transmission(GO:0099551) |
| 0.4 | 4.3 | GO:0006857 | oligopeptide transport(GO:0006857) |
| 0.4 | 1.3 | GO:0007518 | myoblast fate determination(GO:0007518) |
| 0.4 | 1.3 | GO:0035962 | response to interleukin-13(GO:0035962) |
| 0.4 | 0.9 | GO:0036466 | synaptic vesicle recycling via endosome(GO:0036466) |
| 0.4 | 1.7 | GO:0018199 | peptidyl-glutamine modification(GO:0018199) |
| 0.4 | 2.5 | GO:0036493 | positive regulation of translation in response to endoplasmic reticulum stress(GO:0036493) |
| 0.4 | 1.2 | GO:0071460 | cellular response to cell-matrix adhesion(GO:0071460) |
| 0.4 | 0.8 | GO:0002934 | desmosome organization(GO:0002934) |
| 0.4 | 1.6 | GO:0098957 | anterograde axonal transport of mitochondrion(GO:0098957) |
| 0.4 | 16.2 | GO:0018345 | protein palmitoylation(GO:0018345) |
| 0.4 | 1.2 | GO:0031247 | actin rod assembly(GO:0031247) |
| 0.4 | 0.8 | GO:1902174 | positive regulation of keratinocyte apoptotic process(GO:1902174) |
| 0.4 | 7.4 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
| 0.4 | 1.6 | GO:0032185 | septin cytoskeleton organization(GO:0032185) |
| 0.4 | 5.8 | GO:0003334 | keratinocyte development(GO:0003334) |
| 0.4 | 2.3 | GO:0035897 | proteolysis in other organism(GO:0035897) |
| 0.4 | 0.8 | GO:0090031 | positive regulation of steroid hormone biosynthetic process(GO:0090031) |
| 0.4 | 0.4 | GO:0034140 | negative regulation of toll-like receptor 3 signaling pathway(GO:0034140) |
| 0.4 | 1.5 | GO:2000503 | positive regulation of natural killer cell chemotaxis(GO:2000503) |
| 0.4 | 5.9 | GO:0007176 | regulation of epidermal growth factor-activated receptor activity(GO:0007176) |
| 0.4 | 0.4 | GO:2000182 | regulation of progesterone biosynthetic process(GO:2000182) |
| 0.4 | 1.1 | GO:0015917 | aminophospholipid transport(GO:0015917) |
| 0.4 | 5.9 | GO:0031268 | pseudopodium organization(GO:0031268) |
| 0.4 | 7.0 | GO:0023019 | signal transduction involved in regulation of gene expression(GO:0023019) |
| 0.4 | 2.2 | GO:0071461 | cellular response to redox state(GO:0071461) |
| 0.4 | 1.1 | GO:0006663 | platelet activating factor biosynthetic process(GO:0006663) |
| 0.4 | 5.8 | GO:0097296 | activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:0097296) |
| 0.4 | 2.5 | GO:0031339 | negative regulation of vesicle fusion(GO:0031339) |
| 0.4 | 1.4 | GO:0006562 | proline catabolic process(GO:0006562) |
| 0.4 | 0.4 | GO:2000807 | positive regulation of presynaptic membrane organization(GO:1901631) regulation of synaptic vesicle clustering(GO:2000807) positive regulation of synaptic vesicle clustering(GO:2000809) |
| 0.3 | 1.0 | GO:2000382 | positive regulation of mesoderm development(GO:2000382) |
| 0.3 | 16.3 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
| 0.3 | 0.7 | GO:0048733 | sebaceous gland development(GO:0048733) |
| 0.3 | 5.2 | GO:0051665 | membrane raft localization(GO:0051665) |
| 0.3 | 1.0 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
| 0.3 | 2.7 | GO:0034316 | negative regulation of Arp2/3 complex-mediated actin nucleation(GO:0034316) |
| 0.3 | 27.1 | GO:0008088 | axo-dendritic transport(GO:0008088) |
| 0.3 | 2.0 | GO:0006021 | inositol biosynthetic process(GO:0006021) |
| 0.3 | 1.4 | GO:0030472 | mitotic spindle organization in nucleus(GO:0030472) |
| 0.3 | 1.4 | GO:0021623 | oculomotor nerve development(GO:0021557) oculomotor nerve morphogenesis(GO:0021622) oculomotor nerve formation(GO:0021623) |
| 0.3 | 0.7 | GO:0090298 | negative regulation of mitochondrial DNA replication(GO:0090298) negative regulation of mitochondrial DNA metabolic process(GO:1901859) |
| 0.3 | 1.0 | GO:0042727 | flavin-containing compound biosynthetic process(GO:0042727) |
| 0.3 | 1.3 | GO:0006258 | UDP-glucose catabolic process(GO:0006258) |
| 0.3 | 2.0 | GO:0033133 | positive regulation of glucokinase activity(GO:0033133) |
| 0.3 | 1.0 | GO:0072156 | distal tubule morphogenesis(GO:0072156) |
| 0.3 | 7.6 | GO:0045063 | T-helper 1 cell differentiation(GO:0045063) |
| 0.3 | 7.9 | GO:0007250 | activation of NF-kappaB-inducing kinase activity(GO:0007250) |
| 0.3 | 1.6 | GO:0016560 | protein import into peroxisome matrix, docking(GO:0016560) |
| 0.3 | 10.5 | GO:0090004 | positive regulation of establishment of protein localization to plasma membrane(GO:0090004) |
| 0.3 | 2.0 | GO:0032264 | IMP salvage(GO:0032264) |
| 0.3 | 13.4 | GO:0035774 | positive regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0035774) |
| 0.3 | 7.8 | GO:0050716 | positive regulation of interleukin-1 secretion(GO:0050716) |
| 0.3 | 0.6 | GO:2000586 | regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000586) |
| 0.3 | 5.5 | GO:0071481 | cellular response to X-ray(GO:0071481) |
| 0.3 | 13.3 | GO:0051904 | pigment granule transport(GO:0051904) |
| 0.3 | 5.4 | GO:0060706 | cell differentiation involved in embryonic placenta development(GO:0060706) |
| 0.3 | 3.8 | GO:0072205 | metanephric collecting duct development(GO:0072205) |
| 0.3 | 3.8 | GO:0045078 | positive regulation of interferon-gamma biosynthetic process(GO:0045078) |
| 0.3 | 1.6 | GO:0046952 | ketone body catabolic process(GO:0046952) |
| 0.3 | 1.3 | GO:0090156 | cellular sphingolipid homeostasis(GO:0090156) |
| 0.3 | 1.6 | GO:1902473 | regulation of protein localization to synapse(GO:1902473) positive regulation of protein localization to synapse(GO:1902474) |
| 0.3 | 0.3 | GO:0003356 | regulation of cilium beat frequency(GO:0003356) |
| 0.3 | 0.9 | GO:0048617 | foregut morphogenesis(GO:0007440) embryonic foregut morphogenesis(GO:0048617) |
| 0.3 | 1.9 | GO:0032287 | peripheral nervous system myelin maintenance(GO:0032287) |
| 0.3 | 5.2 | GO:0006703 | estrogen biosynthetic process(GO:0006703) |
| 0.3 | 1.2 | GO:0048749 | compound eye development(GO:0048749) |
| 0.3 | 0.3 | GO:0071603 | endothelial cell-cell adhesion(GO:0071603) |
| 0.3 | 4.8 | GO:2000249 | regulation of actin cytoskeleton reorganization(GO:2000249) |
| 0.3 | 0.9 | GO:1902460 | regulation of mesenchymal stem cell proliferation(GO:1902460) positive regulation of mesenchymal stem cell proliferation(GO:1902462) |
| 0.3 | 0.9 | GO:0000117 | regulation of transcription involved in G2/M transition of mitotic cell cycle(GO:0000117) |
| 0.3 | 3.0 | GO:0019227 | neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
| 0.3 | 0.6 | GO:1901876 | regulation of calcium ion binding(GO:1901876) negative regulation of calcium ion binding(GO:1901877) |
| 0.3 | 0.9 | GO:0009644 | response to high light intensity(GO:0009644) |
| 0.3 | 1.5 | GO:0045084 | positive regulation of interleukin-12 biosynthetic process(GO:0045084) |
| 0.3 | 0.3 | GO:0009794 | regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
| 0.3 | 0.9 | GO:0006106 | fumarate metabolic process(GO:0006106) aspartate biosynthetic process(GO:0006532) aspartate catabolic process(GO:0006533) 4-hydroxyproline catabolic process(GO:0019470) |
| 0.3 | 0.6 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
| 0.3 | 0.9 | GO:0061182 | negative regulation of chondrocyte development(GO:0061182) |
| 0.3 | 1.2 | GO:0097089 | methyl-branched fatty acid metabolic process(GO:0097089) |
| 0.3 | 2.6 | GO:0019375 | galactosylceramide biosynthetic process(GO:0006682) galactolipid biosynthetic process(GO:0019375) |
| 0.3 | 0.9 | GO:0046379 | extracellular polysaccharide biosynthetic process(GO:0045226) extracellular polysaccharide metabolic process(GO:0046379) |
| 0.3 | 0.9 | GO:0035744 | myeloid dendritic cell activation involved in immune response(GO:0002277) T-helper 1 cell cytokine production(GO:0035744) |
| 0.3 | 1.7 | GO:0070995 | NADPH oxidation(GO:0070995) |
| 0.3 | 1.1 | GO:0034093 | positive regulation of maintenance of sister chromatid cohesion(GO:0034093) positive regulation of maintenance of mitotic sister chromatid cohesion(GO:0034184) |
| 0.3 | 12.9 | GO:0046627 | negative regulation of insulin receptor signaling pathway(GO:0046627) |
| 0.3 | 0.8 | GO:2001286 | regulation of caveolin-mediated endocytosis(GO:2001286) |
| 0.3 | 2.2 | GO:1901187 | regulation of ephrin receptor signaling pathway(GO:1901187) |
| 0.3 | 29.1 | GO:0070268 | cornification(GO:0070268) |
| 0.3 | 1.1 | GO:0061370 | testosterone biosynthetic process(GO:0061370) |
| 0.3 | 4.0 | GO:1904152 | regulation of retrograde protein transport, ER to cytosol(GO:1904152) |
| 0.3 | 0.8 | GO:0001207 | histone displacement(GO:0001207) positive regulation of transcription involved in meiotic cell cycle(GO:0051039) |
| 0.3 | 1.1 | GO:0007000 | nucleolus organization(GO:0007000) |
| 0.3 | 28.7 | GO:0006970 | response to osmotic stress(GO:0006970) |
| 0.3 | 1.8 | GO:0030174 | regulation of DNA-dependent DNA replication initiation(GO:0030174) |
| 0.3 | 0.5 | GO:0003218 | cardiac left ventricle formation(GO:0003218) |
| 0.3 | 1.0 | GO:0006172 | ADP biosynthetic process(GO:0006172) |
| 0.3 | 2.6 | GO:0033623 | regulation of integrin activation(GO:0033623) |
| 0.3 | 7.8 | GO:0007141 | male meiosis I(GO:0007141) |
| 0.3 | 3.3 | GO:0006516 | glycoprotein catabolic process(GO:0006516) |
| 0.3 | 2.1 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
| 0.3 | 1.8 | GO:0097475 | motor neuron migration(GO:0097475) |
| 0.3 | 1.0 | GO:0036302 | atrioventricular canal development(GO:0036302) |
| 0.3 | 1.3 | GO:1990928 | response to amino acid starvation(GO:1990928) |
| 0.3 | 5.3 | GO:0045104 | intermediate filament cytoskeleton organization(GO:0045104) |
| 0.2 | 8.0 | GO:0042572 | retinol metabolic process(GO:0042572) |
| 0.2 | 0.7 | GO:0045163 | clustering of voltage-gated potassium channels(GO:0045163) |
| 0.2 | 0.7 | GO:0001732 | formation of cytoplasmic translation initiation complex(GO:0001732) |
| 0.2 | 1.2 | GO:0001575 | globoside metabolic process(GO:0001575) |
| 0.2 | 3.1 | GO:0035767 | endothelial cell chemotaxis(GO:0035767) |
| 0.2 | 0.7 | GO:0033076 | isoquinoline alkaloid metabolic process(GO:0033076) |
| 0.2 | 0.7 | GO:1990535 | negative regulation of calcineurin-NFAT signaling cascade(GO:0070885) neuron projection maintenance(GO:1990535) |
| 0.2 | 0.7 | GO:0042776 | mitochondrial ATP synthesis coupled proton transport(GO:0042776) |
| 0.2 | 0.7 | GO:0035900 | response to isolation stress(GO:0035900) |
| 0.2 | 9.3 | GO:0007638 | mechanosensory behavior(GO:0007638) |
| 0.2 | 0.7 | GO:0016185 | synaptic vesicle budding from presynaptic endocytic zone membrane(GO:0016185) |
| 0.2 | 0.7 | GO:0038163 | thrombopoietin-mediated signaling pathway(GO:0038163) |
| 0.2 | 2.1 | GO:1903546 | receptor localization to nonmotile primary cilium(GO:0097500) protein localization to photoreceptor outer segment(GO:1903546) |
| 0.2 | 39.5 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
| 0.2 | 0.7 | GO:0060723 | spongiotrophoblast cell proliferation(GO:0060720) regulation of spongiotrophoblast cell proliferation(GO:0060721) cell proliferation involved in embryonic placenta development(GO:0060722) regulation of cell proliferation involved in embryonic placenta development(GO:0060723) |
| 0.2 | 0.7 | GO:0001787 | natural killer cell proliferation(GO:0001787) |
| 0.2 | 2.9 | GO:0002315 | marginal zone B cell differentiation(GO:0002315) |
| 0.2 | 3.6 | GO:0017121 | phospholipid scrambling(GO:0017121) |
| 0.2 | 2.0 | GO:1902510 | regulation of apoptotic DNA fragmentation(GO:1902510) |
| 0.2 | 0.9 | GO:0019355 | nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
| 0.2 | 1.3 | GO:0098989 | NMDA selective glutamate receptor signaling pathway(GO:0098989) |
| 0.2 | 0.4 | GO:0002830 | positive regulation of type 2 immune response(GO:0002830) |
| 0.2 | 2.5 | GO:0014029 | neural crest formation(GO:0014029) |
| 0.2 | 0.4 | GO:0045819 | positive regulation of glycogen catabolic process(GO:0045819) |
| 0.2 | 0.7 | GO:0098758 | response to interleukin-8(GO:0098758) cellular response to interleukin-8(GO:0098759) |
| 0.2 | 1.1 | GO:1901093 | regulation of protein tetramerization(GO:1901090) negative regulation of protein tetramerization(GO:1901091) regulation of protein homotetramerization(GO:1901093) negative regulation of protein homotetramerization(GO:1901094) |
| 0.2 | 3.1 | GO:0001913 | T cell mediated cytotoxicity(GO:0001913) |
| 0.2 | 1.3 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
| 0.2 | 0.4 | GO:0043382 | positive regulation of memory T cell differentiation(GO:0043382) |
| 0.2 | 5.8 | GO:0032878 | regulation of establishment or maintenance of cell polarity(GO:0032878) |
| 0.2 | 2.8 | GO:0006264 | mitochondrial DNA replication(GO:0006264) |
| 0.2 | 1.3 | GO:0032494 | response to peptidoglycan(GO:0032494) |
| 0.2 | 3.2 | GO:0030277 | maintenance of gastrointestinal epithelium(GO:0030277) |
| 0.2 | 1.9 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
| 0.2 | 4.2 | GO:1904776 | regulation of protein localization to cell cortex(GO:1904776) positive regulation of protein localization to cell cortex(GO:1904778) |
| 0.2 | 5.5 | GO:0097503 | sialylation(GO:0097503) |
| 0.2 | 1.5 | GO:0098700 | neurotransmitter loading into synaptic vesicle(GO:0098700) |
| 0.2 | 0.2 | GO:0035691 | macrophage migration inhibitory factor signaling pathway(GO:0035691) |
| 0.2 | 2.7 | GO:0072015 | glomerular visceral epithelial cell development(GO:0072015) |
| 0.2 | 0.8 | GO:2000402 | negative regulation of lymphocyte migration(GO:2000402) |
| 0.2 | 2.1 | GO:0040038 | polar body extrusion after meiotic divisions(GO:0040038) |
| 0.2 | 13.9 | GO:0007032 | endosome organization(GO:0007032) |
| 0.2 | 0.6 | GO:0003011 | involuntary skeletal muscle contraction(GO:0003011) |
| 0.2 | 0.6 | GO:0060022 | hard palate development(GO:0060022) |
| 0.2 | 0.8 | GO:0009838 | abscission(GO:0009838) mitotic cytokinesis checkpoint(GO:0044878) |
| 0.2 | 0.8 | GO:0098886 | modification of dendritic spine(GO:0098886) |
| 0.2 | 1.2 | GO:1902731 | ovarian cumulus expansion(GO:0001550) fused antrum stage(GO:0048165) negative regulation of chondrocyte proliferation(GO:1902731) |
| 0.2 | 1.4 | GO:0048840 | otolith development(GO:0048840) |
| 0.2 | 1.4 | GO:0033353 | S-adenosylmethionine cycle(GO:0033353) |
| 0.2 | 0.6 | GO:2000819 | regulation of nucleotide-excision repair(GO:2000819) |
| 0.2 | 1.0 | GO:1904764 | late endosomal microautophagy(GO:0061738) negative regulation of fibril organization(GO:1902904) chaperone-mediated autophagy translocation complex disassembly(GO:1904764) |
| 0.2 | 0.8 | GO:0000821 | regulation of arginine metabolic process(GO:0000821) |
| 0.2 | 1.2 | GO:0033504 | floor plate development(GO:0033504) |
| 0.2 | 3.2 | GO:0006704 | glucocorticoid biosynthetic process(GO:0006704) |
| 0.2 | 6.3 | GO:0015695 | organic cation transport(GO:0015695) |
| 0.2 | 2.0 | GO:0002480 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent(GO:0002480) |
| 0.2 | 1.9 | GO:0015732 | prostaglandin transport(GO:0015732) |
| 0.2 | 0.4 | GO:0033686 | positive regulation of luteinizing hormone secretion(GO:0033686) |
| 0.2 | 1.0 | GO:0000379 | tRNA-type intron splice site recognition and cleavage(GO:0000379) |
| 0.2 | 2.3 | GO:1903690 | negative regulation of wound healing, spreading of epidermal cells(GO:1903690) |
| 0.2 | 0.9 | GO:0044209 | AMP salvage(GO:0044209) |
| 0.2 | 0.6 | GO:0036265 | RNA (guanine-N7)-methylation(GO:0036265) rRNA (guanine-N7)-methylation(GO:0070476) |
| 0.2 | 1.9 | GO:0046033 | AMP metabolic process(GO:0046033) |
| 0.2 | 0.6 | GO:0002316 | follicular B cell differentiation(GO:0002316) |
| 0.2 | 0.7 | GO:0046368 | GDP-L-fucose metabolic process(GO:0046368) |
| 0.2 | 0.9 | GO:0001866 | NK T cell proliferation(GO:0001866) |
| 0.2 | 1.1 | GO:0032364 | oxygen homeostasis(GO:0032364) |
| 0.2 | 0.9 | GO:0009624 | response to nematode(GO:0009624) |
| 0.2 | 0.9 | GO:0001878 | response to yeast(GO:0001878) |
| 0.2 | 2.8 | GO:0071318 | cellular response to ATP(GO:0071318) |
| 0.2 | 3.7 | GO:0015868 | purine ribonucleotide transport(GO:0015868) |
| 0.2 | 1.5 | GO:0032049 | cardiolipin biosynthetic process(GO:0032049) |
| 0.2 | 3.4 | GO:0043011 | myeloid dendritic cell differentiation(GO:0043011) |
| 0.2 | 0.5 | GO:0051987 | positive regulation of attachment of spindle microtubules to kinetochore(GO:0051987) |
| 0.2 | 1.2 | GO:0030046 | parallel actin filament bundle assembly(GO:0030046) |
| 0.2 | 3.5 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
| 0.2 | 3.7 | GO:0033169 | histone H3-K9 demethylation(GO:0033169) |
| 0.2 | 0.4 | GO:0044205 | 'de novo' UMP biosynthetic process(GO:0044205) |
| 0.2 | 0.7 | GO:0009236 | cobalamin biosynthetic process(GO:0009236) |
| 0.2 | 1.6 | GO:0046465 | dolichyl diphosphate biosynthetic process(GO:0006489) dolichyl diphosphate metabolic process(GO:0046465) |
| 0.2 | 6.2 | GO:0050918 | positive chemotaxis(GO:0050918) |
| 0.2 | 1.4 | GO:1903012 | positive regulation of bone development(GO:1903012) |
| 0.2 | 2.9 | GO:0060575 | intestinal epithelial cell differentiation(GO:0060575) |
| 0.2 | 0.8 | GO:0032957 | inositol trisphosphate metabolic process(GO:0032957) |
| 0.2 | 1.0 | GO:0035995 | detection of muscle stretch(GO:0035995) |
| 0.2 | 2.0 | GO:0044821 | meiotic telomere tethering at nuclear periphery(GO:0044821) meiotic attachment of telomere to nuclear envelope(GO:0070197) chromosome attachment to the nuclear envelope(GO:0097240) |
| 0.2 | 0.3 | GO:0003350 | pulmonary myocardium development(GO:0003350) |
| 0.2 | 1.0 | GO:0060754 | positive regulation of mast cell chemotaxis(GO:0060754) |
| 0.2 | 0.8 | GO:0093001 | glycolysis from storage polysaccharide through glucose-1-phosphate(GO:0093001) |
| 0.2 | 0.7 | GO:0002143 | tRNA wobble position uridine thiolation(GO:0002143) |
| 0.2 | 5.9 | GO:0050691 | regulation of defense response to virus by host(GO:0050691) |
| 0.2 | 1.2 | GO:0097011 | cellular response to granulocyte macrophage colony-stimulating factor stimulus(GO:0097011) response to granulocyte macrophage colony-stimulating factor(GO:0097012) |
| 0.2 | 8.2 | GO:0050690 | regulation of defense response to virus by virus(GO:0050690) |
| 0.2 | 0.7 | GO:0050482 | arachidonic acid secretion(GO:0050482) arachidonate transport(GO:1903963) |
| 0.2 | 0.2 | GO:1901166 | neural crest cell migration involved in autonomic nervous system development(GO:1901166) |
| 0.2 | 0.8 | GO:0009233 | menaquinone metabolic process(GO:0009233) |
| 0.2 | 0.2 | GO:2001268 | negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001268) |
| 0.2 | 2.4 | GO:0042554 | superoxide anion generation(GO:0042554) |
| 0.2 | 8.8 | GO:0046513 | ceramide biosynthetic process(GO:0046513) |
| 0.2 | 0.2 | GO:0019075 | virus maturation(GO:0019075) |
| 0.2 | 2.0 | GO:0036158 | outer dynein arm assembly(GO:0036158) |
| 0.2 | 0.8 | GO:0032484 | Ral protein signal transduction(GO:0032484) regulation of Ral protein signal transduction(GO:0032485) |
| 0.2 | 1.1 | GO:1900264 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
| 0.2 | 1.2 | GO:0071468 | cellular response to acidic pH(GO:0071468) |
| 0.2 | 1.4 | GO:1900028 | negative regulation of ruffle assembly(GO:1900028) |
| 0.2 | 0.6 | GO:1904628 | response to phorbol 13-acetate 12-myristate(GO:1904627) cellular response to phorbol 13-acetate 12-myristate(GO:1904628) |
| 0.2 | 1.7 | GO:0045780 | positive regulation of bone resorption(GO:0045780) positive regulation of bone remodeling(GO:0046852) |
| 0.2 | 1.2 | GO:0006771 | riboflavin metabolic process(GO:0006771) riboflavin transport(GO:0032218) |
| 0.1 | 0.7 | GO:0000393 | spliceosomal conformational changes to generate catalytic conformation(GO:0000393) |
| 0.1 | 1.3 | GO:0090160 | Golgi to lysosome transport(GO:0090160) |
| 0.1 | 0.7 | GO:0060019 | radial glial cell differentiation(GO:0060019) |
| 0.1 | 0.9 | GO:0070475 | rRNA base methylation(GO:0070475) |
| 0.1 | 0.3 | GO:0042908 | xenobiotic transport(GO:0042908) |
| 0.1 | 1.2 | GO:0060287 | epithelial cilium movement involved in determination of left/right asymmetry(GO:0060287) |
| 0.1 | 0.3 | GO:0097694 | establishment of RNA localization to telomere(GO:0097694) establishment of macromolecular complex localization to telomere(GO:0097695) |
| 0.1 | 0.7 | GO:0060050 | positive regulation of protein glycosylation(GO:0060050) |
| 0.1 | 0.6 | GO:0097119 | postsynaptic density protein 95 clustering(GO:0097119) |
| 0.1 | 0.7 | GO:0042986 | positive regulation of amyloid precursor protein biosynthetic process(GO:0042986) |
| 0.1 | 0.9 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
| 0.1 | 0.8 | GO:1903862 | positive regulation of oxidative phosphorylation(GO:1903862) |
| 0.1 | 6.6 | GO:0042058 | regulation of epidermal growth factor receptor signaling pathway(GO:0042058) |
| 0.1 | 0.4 | GO:2000348 | regulation of CD40 signaling pathway(GO:2000348) |
| 0.1 | 2.4 | GO:0060347 | heart trabecula formation(GO:0060347) |
| 0.1 | 1.0 | GO:0000389 | mRNA 3'-splice site recognition(GO:0000389) |
| 0.1 | 1.7 | GO:2000291 | regulation of myoblast proliferation(GO:2000291) |
| 0.1 | 1.3 | GO:0002084 | protein depalmitoylation(GO:0002084) |
| 0.1 | 0.6 | GO:0060023 | soft palate development(GO:0060023) |
| 0.1 | 1.5 | GO:0006884 | cell volume homeostasis(GO:0006884) |
| 0.1 | 0.6 | GO:0060296 | regulation of cilium movement involved in cell motility(GO:0060295) regulation of cilium beat frequency involved in ciliary motility(GO:0060296) regulation of cilium-dependent cell motility(GO:1902019) |
| 0.1 | 2.9 | GO:0070262 | peptidyl-serine dephosphorylation(GO:0070262) |
| 0.1 | 2.1 | GO:1900745 | positive regulation of p38MAPK cascade(GO:1900745) |
| 0.1 | 1.4 | GO:0036120 | response to platelet-derived growth factor(GO:0036119) cellular response to platelet-derived growth factor stimulus(GO:0036120) |
| 0.1 | 1.0 | GO:0060125 | negative regulation of growth hormone secretion(GO:0060125) |
| 0.1 | 2.5 | GO:0035584 | calcium-mediated signaling using intracellular calcium source(GO:0035584) |
| 0.1 | 0.8 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
| 0.1 | 1.5 | GO:0015886 | heme transport(GO:0015886) |
| 0.1 | 13.4 | GO:0010923 | negative regulation of phosphatase activity(GO:0010923) |
| 0.1 | 2.3 | GO:1903830 | magnesium ion transmembrane transport(GO:1903830) |
| 0.1 | 6.1 | GO:0007340 | acrosome reaction(GO:0007340) |
| 0.1 | 1.5 | GO:0043517 | positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) |
| 0.1 | 0.5 | GO:1902775 | mitochondrial large ribosomal subunit assembly(GO:1902775) |
| 0.1 | 0.6 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
| 0.1 | 0.5 | GO:1904694 | negative regulation of vascular smooth muscle contraction(GO:1904694) |
| 0.1 | 1.4 | GO:0001675 | acrosome assembly(GO:0001675) |
| 0.1 | 0.4 | GO:0043553 | negative regulation of phosphatidylinositol 3-kinase activity(GO:0043553) |
| 0.1 | 6.5 | GO:0048384 | retinoic acid receptor signaling pathway(GO:0048384) |
| 0.1 | 0.6 | GO:0010940 | positive regulation of necrotic cell death(GO:0010940) |
| 0.1 | 1.6 | GO:0035372 | protein localization to microtubule(GO:0035372) |
| 0.1 | 2.8 | GO:0034776 | response to histamine(GO:0034776) cellular response to histamine(GO:0071420) |
| 0.1 | 2.1 | GO:0000050 | urea cycle(GO:0000050) |
| 0.1 | 0.6 | GO:0045086 | positive regulation of interleukin-2 biosynthetic process(GO:0045086) |
| 0.1 | 0.5 | GO:0030576 | Cajal body organization(GO:0030576) |
| 0.1 | 0.7 | GO:0071910 | determination of pancreatic left/right asymmetry(GO:0035469) determination of liver left/right asymmetry(GO:0071910) |
| 0.1 | 1.3 | GO:0035095 | behavioral response to nicotine(GO:0035095) |
| 0.1 | 0.8 | GO:0035860 | glial cell-derived neurotrophic factor receptor signaling pathway(GO:0035860) |
| 0.1 | 0.2 | GO:1902304 | positive regulation of potassium ion export(GO:1902304) |
| 0.1 | 1.3 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
| 0.1 | 1.9 | GO:0097201 | negative regulation of transcription from RNA polymerase II promoter in response to stress(GO:0097201) |
| 0.1 | 0.8 | GO:0043653 | mitochondrial fragmentation involved in apoptotic process(GO:0043653) |
| 0.1 | 1.2 | GO:0010668 | ectodermal cell differentiation(GO:0010668) |
| 0.1 | 0.5 | GO:0045917 | positive regulation of complement activation(GO:0045917) positive regulation of protein activation cascade(GO:2000259) |
| 0.1 | 3.3 | GO:0009649 | entrainment of circadian clock(GO:0009649) |
| 0.1 | 1.7 | GO:0015884 | folic acid transport(GO:0015884) |
| 0.1 | 0.7 | GO:0070829 | response to vitamin B2(GO:0033274) heterochromatin maintenance(GO:0070829) |
| 0.1 | 0.8 | GO:2000628 | regulation of miRNA metabolic process(GO:2000628) |
| 0.1 | 0.4 | GO:0033152 | immunoglobulin V(D)J recombination(GO:0033152) |
| 0.1 | 0.2 | GO:1902595 | regulation of DNA replication origin binding(GO:1902595) |
| 0.1 | 0.2 | GO:1903689 | regulation of wound healing, spreading of epidermal cells(GO:1903689) |
| 0.1 | 0.2 | GO:0048496 | maintenance of organ identity(GO:0048496) |
| 0.1 | 2.4 | GO:2000369 | regulation of clathrin-mediated endocytosis(GO:2000369) |
| 0.1 | 0.1 | GO:0032831 | regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0032829) positive regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0032831) |
| 0.1 | 1.3 | GO:0019344 | cysteine biosynthetic process(GO:0019344) |
| 0.1 | 1.7 | GO:0038003 | opioid receptor signaling pathway(GO:0038003) |
| 0.1 | 5.5 | GO:0055078 | sodium ion homeostasis(GO:0055078) |
| 0.1 | 1.7 | GO:0045116 | protein neddylation(GO:0045116) |
| 0.1 | 0.5 | GO:0051661 | maintenance of centrosome location(GO:0051661) |
| 0.1 | 0.9 | GO:0045039 | protein import into mitochondrial inner membrane(GO:0045039) |
| 0.1 | 0.8 | GO:0060059 | embryonic retina morphogenesis in camera-type eye(GO:0060059) |
| 0.1 | 0.4 | GO:0021978 | telencephalon regionalization(GO:0021978) |
| 0.1 | 2.3 | GO:0046339 | diacylglycerol metabolic process(GO:0046339) |
| 0.1 | 1.3 | GO:0021520 | spinal cord motor neuron cell fate specification(GO:0021520) |
| 0.1 | 0.3 | GO:0030573 | bile acid catabolic process(GO:0030573) |
| 0.1 | 0.1 | GO:0072429 | response to intra-S DNA damage checkpoint signaling(GO:0072429) |
| 0.1 | 0.7 | GO:0060749 | mammary gland alveolus development(GO:0060749) mammary gland lobule development(GO:0061377) |
| 0.1 | 0.8 | GO:0021819 | layer formation in cerebral cortex(GO:0021819) |
| 0.1 | 1.5 | GO:0010666 | positive regulation of striated muscle cell apoptotic process(GO:0010663) positive regulation of cardiac muscle cell apoptotic process(GO:0010666) |
| 0.1 | 0.9 | GO:1904879 | positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel(GO:1904879) |
| 0.1 | 0.4 | GO:0046016 | regulation of transcription from RNA polymerase II promoter by glucose(GO:0000430) positive regulation of transcription from RNA polymerase II promoter by glucose(GO:0000432) positive regulation of transcription by glucose(GO:0046016) |
| 0.1 | 2.5 | GO:0035115 | embryonic forelimb morphogenesis(GO:0035115) |
| 0.1 | 0.4 | GO:0008616 | queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
| 0.1 | 0.3 | GO:1904158 | axonemal central apparatus assembly(GO:1904158) |
| 0.1 | 0.3 | GO:1904970 | brush border assembly(GO:1904970) |
| 0.1 | 1.1 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
| 0.1 | 0.3 | GO:0010956 | negative regulation of calcidiol 1-monooxygenase activity(GO:0010956) regulation of interleukin-6-mediated signaling pathway(GO:0070103) positive regulation of interleukin-6-mediated signaling pathway(GO:0070105) |
| 0.1 | 2.4 | GO:1901663 | ubiquinone metabolic process(GO:0006743) ubiquinone biosynthetic process(GO:0006744) quinone biosynthetic process(GO:1901663) |
| 0.1 | 1.0 | GO:0045329 | carnitine biosynthetic process(GO:0045329) |
| 0.1 | 0.9 | GO:0010614 | negative regulation of cardiac muscle hypertrophy(GO:0010614) |
| 0.1 | 0.6 | GO:0019236 | response to pheromone(GO:0019236) |
| 0.1 | 0.1 | GO:1904304 | regulation of gastro-intestinal system smooth muscle contraction(GO:1904304) positive regulation of gastro-intestinal system smooth muscle contraction(GO:1904306) |
| 0.1 | 0.3 | GO:0044179 | cytolysis by symbiont of host cells(GO:0001897) hemolysis by symbiont of host erythrocytes(GO:0019836) hemolysis in other organism(GO:0044179) hemolysis in other organism involved in symbiotic interaction(GO:0052331) |
| 0.1 | 1.7 | GO:0072663 | protein targeting to peroxisome(GO:0006625) protein localization to peroxisome(GO:0072662) establishment of protein localization to peroxisome(GO:0072663) |
| 0.1 | 1.3 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
| 0.1 | 2.8 | GO:0045746 | negative regulation of Notch signaling pathway(GO:0045746) |
| 0.1 | 0.8 | GO:0061299 | retina vasculature morphogenesis in camera-type eye(GO:0061299) |
| 0.1 | 1.6 | GO:2000059 | negative regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000059) |
| 0.1 | 1.6 | GO:0070932 | histone H3 deacetylation(GO:0070932) |
| 0.1 | 1.1 | GO:2000622 | regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
| 0.1 | 1.1 | GO:0002862 | negative regulation of inflammatory response to antigenic stimulus(GO:0002862) |
| 0.1 | 1.8 | GO:0043552 | positive regulation of phosphatidylinositol 3-kinase activity(GO:0043552) |
| 0.1 | 1.0 | GO:0019388 | galactose catabolic process(GO:0019388) |
| 0.1 | 1.3 | GO:0031293 | membrane protein intracellular domain proteolysis(GO:0031293) |
| 0.1 | 1.7 | GO:0030150 | protein import into mitochondrial matrix(GO:0030150) |
| 0.1 | 1.4 | GO:1904262 | negative regulation of TORC1 signaling(GO:1904262) |
| 0.1 | 0.9 | GO:0099500 | synaptic vesicle fusion to presynaptic active zone membrane(GO:0031629) vesicle fusion to plasma membrane(GO:0099500) |
| 0.1 | 1.3 | GO:0090023 | positive regulation of neutrophil chemotaxis(GO:0090023) |
| 0.1 | 0.3 | GO:0002774 | positive regulation of T cell tolerance induction(GO:0002666) Fc receptor mediated inhibitory signaling pathway(GO:0002774) |
| 0.1 | 2.7 | GO:0051646 | mitochondrion localization(GO:0051646) |
| 0.1 | 0.5 | GO:1990253 | cellular response to leucine starvation(GO:1990253) |
| 0.1 | 0.7 | GO:0002335 | mature B cell differentiation(GO:0002335) |
| 0.1 | 0.4 | GO:0006287 | base-excision repair, gap-filling(GO:0006287) |
| 0.1 | 0.7 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
| 0.1 | 1.9 | GO:0016254 | preassembly of GPI anchor in ER membrane(GO:0016254) |
| 0.1 | 1.2 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
| 0.1 | 0.5 | GO:0097623 | potassium ion export across plasma membrane(GO:0097623) |
| 0.1 | 0.7 | GO:0070233 | negative regulation of T cell apoptotic process(GO:0070233) |
| 0.1 | 0.4 | GO:0090168 | Golgi reassembly(GO:0090168) |
| 0.1 | 0.4 | GO:0042045 | epithelial fluid transport(GO:0042045) |
| 0.1 | 1.5 | GO:0005980 | glycogen catabolic process(GO:0005980) |
| 0.1 | 1.0 | GO:0052696 | flavonoid glucuronidation(GO:0052696) xenobiotic glucuronidation(GO:0052697) |
| 0.1 | 0.6 | GO:0016557 | peroxisome membrane biogenesis(GO:0016557) regulation of peroxisome size(GO:0044375) |
| 0.1 | 1.2 | GO:0043555 | regulation of translation in response to stress(GO:0043555) |
| 0.1 | 2.1 | GO:0030488 | tRNA methylation(GO:0030488) |
| 0.1 | 0.3 | GO:0045065 | cytotoxic T cell differentiation(GO:0045065) |
| 0.1 | 0.2 | GO:0051835 | positive regulation of synapse structural plasticity(GO:0051835) |
| 0.1 | 0.1 | GO:0016191 | synaptic vesicle uncoating(GO:0016191) |
| 0.1 | 0.8 | GO:1900864 | mitochondrial tRNA modification(GO:0070900) mitochondrial RNA modification(GO:1900864) |
| 0.1 | 0.4 | GO:0090070 | positive regulation of ribosome biogenesis(GO:0090070) positive regulation of rRNA processing(GO:2000234) |
| 0.1 | 0.4 | GO:1903826 | arginine transmembrane transport(GO:1903826) |
| 0.1 | 0.3 | GO:0030423 | targeting of mRNA for destruction involved in RNA interference(GO:0030423) |
| 0.1 | 0.4 | GO:0008228 | opsonization(GO:0008228) |
| 0.1 | 0.9 | GO:0044030 | regulation of DNA methylation(GO:0044030) |
| 0.1 | 0.2 | GO:0032429 | regulation of phospholipase A2 activity(GO:0032429) positive regulation of phospholipase A2 activity(GO:0032430) |
| 0.1 | 0.3 | GO:0003228 | atrial cardiac muscle tissue development(GO:0003228) atrial cardiac muscle tissue morphogenesis(GO:0055009) |
| 0.1 | 0.5 | GO:0035616 | histone H2B conserved C-terminal lysine deubiquitination(GO:0035616) |
| 0.1 | 0.8 | GO:0015781 | pyrimidine nucleotide-sugar transport(GO:0015781) |
| 0.1 | 0.7 | GO:0035634 | response to stilbenoid(GO:0035634) |
| 0.1 | 0.1 | GO:0071467 | cellular response to pH(GO:0071467) |
| 0.1 | 0.3 | GO:0097104 | postsynaptic membrane assembly(GO:0097104) |
| 0.1 | 0.3 | GO:0006990 | positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response(GO:0006990) |
| 0.1 | 1.3 | GO:0032225 | regulation of synaptic transmission, dopaminergic(GO:0032225) |
| 0.1 | 0.3 | GO:0016480 | negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
| 0.1 | 0.6 | GO:0009249 | protein lipoylation(GO:0009249) |
| 0.1 | 2.3 | GO:0006400 | tRNA modification(GO:0006400) |
| 0.1 | 1.2 | GO:1900087 | positive regulation of G1/S transition of mitotic cell cycle(GO:1900087) |
| 0.1 | 0.3 | GO:0071787 | endoplasmic reticulum tubular network assembly(GO:0071787) |
| 0.1 | 1.2 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
| 0.1 | 0.8 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
| 0.1 | 1.2 | GO:0007216 | G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
| 0.1 | 0.4 | GO:0044806 | G-quadruplex DNA unwinding(GO:0044806) |
| 0.1 | 0.5 | GO:2000271 | positive regulation of fibroblast apoptotic process(GO:2000271) |
| 0.1 | 1.0 | GO:0033141 | positive regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033141) |
| 0.1 | 0.2 | GO:0045903 | positive regulation of translational fidelity(GO:0045903) |
| 0.1 | 0.2 | GO:0032077 | positive regulation of deoxyribonuclease activity(GO:0032077) |
| 0.1 | 0.2 | GO:0098735 | positive regulation of the force of heart contraction(GO:0098735) |
| 0.1 | 1.2 | GO:0006308 | DNA catabolic process(GO:0006308) |
| 0.1 | 0.4 | GO:0042985 | negative regulation of amyloid precursor protein biosynthetic process(GO:0042985) |
| 0.1 | 1.2 | GO:0000729 | DNA double-strand break processing(GO:0000729) |
| 0.1 | 0.2 | GO:0070315 | G1 to G0 transition involved in cell differentiation(GO:0070315) |
| 0.1 | 2.9 | GO:0031424 | keratinization(GO:0031424) |
| 0.1 | 0.3 | GO:0000255 | allantoin metabolic process(GO:0000255) |
| 0.1 | 0.7 | GO:0007007 | inner mitochondrial membrane organization(GO:0007007) |
| 0.1 | 0.3 | GO:0051988 | regulation of attachment of spindle microtubules to kinetochore(GO:0051988) |
| 0.1 | 0.6 | GO:1902236 | negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902236) |
| 0.1 | 1.7 | GO:0008347 | glial cell migration(GO:0008347) |
| 0.1 | 0.4 | GO:0030242 | pexophagy(GO:0030242) |
| 0.1 | 0.3 | GO:0032483 | regulation of Rab protein signal transduction(GO:0032483) |
| 0.1 | 0.2 | GO:1901253 | negative regulation of intracellular transport of viral material(GO:1901253) |
| 0.1 | 0.5 | GO:0002087 | regulation of respiratory gaseous exchange by neurological system process(GO:0002087) |
| 0.1 | 0.6 | GO:0034501 | protein localization to kinetochore(GO:0034501) |
| 0.1 | 2.7 | GO:0050879 | multicellular organismal movement(GO:0050879) musculoskeletal movement(GO:0050881) |
| 0.1 | 0.3 | GO:0009134 | nucleoside diphosphate catabolic process(GO:0009134) |
| 0.1 | 0.4 | GO:0042048 | olfactory behavior(GO:0042048) |
| 0.1 | 0.3 | GO:0071285 | cellular response to lithium ion(GO:0071285) |
| 0.1 | 0.5 | GO:0038092 | nodal signaling pathway(GO:0038092) |
| 0.1 | 0.7 | GO:0006103 | 2-oxoglutarate metabolic process(GO:0006103) |
| 0.1 | 0.1 | GO:0002019 | regulation of renal output by angiotensin(GO:0002019) |
| 0.1 | 0.3 | GO:0009048 | dosage compensation(GO:0007549) dosage compensation by inactivation of X chromosome(GO:0009048) |
| 0.0 | 1.0 | GO:0036152 | phosphatidylethanolamine acyl-chain remodeling(GO:0036152) |
| 0.0 | 0.3 | GO:0035093 | spermatogenesis, exchange of chromosomal proteins(GO:0035093) |
| 0.0 | 0.7 | GO:1902187 | negative regulation of viral release from host cell(GO:1902187) |
| 0.0 | 1.2 | GO:0030513 | positive regulation of BMP signaling pathway(GO:0030513) |
| 0.0 | 0.2 | GO:0010459 | negative regulation of heart rate(GO:0010459) |
| 0.0 | 1.9 | GO:0033574 | response to testosterone(GO:0033574) |
| 0.0 | 0.3 | GO:0008295 | spermidine biosynthetic process(GO:0008295) |
| 0.0 | 1.1 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
| 0.0 | 0.7 | GO:0090200 | positive regulation of release of cytochrome c from mitochondria(GO:0090200) |
| 0.0 | 1.0 | GO:0048714 | positive regulation of oligodendrocyte differentiation(GO:0048714) |
| 0.0 | 0.1 | GO:0072344 | rescue of stalled ribosome(GO:0072344) |
| 0.0 | 0.8 | GO:0060425 | lung morphogenesis(GO:0060425) |
| 0.0 | 0.3 | GO:0097428 | protein maturation by iron-sulfur cluster transfer(GO:0097428) |
| 0.0 | 1.2 | GO:1903959 | regulation of anion transmembrane transport(GO:1903959) |
| 0.0 | 0.5 | GO:0015824 | proline transport(GO:0015824) |
| 0.0 | 0.3 | GO:0097052 | L-kynurenine metabolic process(GO:0097052) |
| 0.0 | 0.2 | GO:2000312 | regulation of kainate selective glutamate receptor activity(GO:2000312) |
| 0.0 | 0.3 | GO:0061732 | mitochondrial acetyl-CoA biosynthetic process from pyruvate(GO:0061732) |
| 0.0 | 0.7 | GO:1902894 | negative regulation of pri-miRNA transcription from RNA polymerase II promoter(GO:1902894) |
| 0.0 | 0.3 | GO:0075525 | viral translational termination-reinitiation(GO:0075525) |
| 0.0 | 0.4 | GO:0035855 | megakaryocyte development(GO:0035855) |
| 0.0 | 0.5 | GO:0043666 | regulation of phosphoprotein phosphatase activity(GO:0043666) |
| 0.0 | 0.2 | GO:0002191 | cap-dependent translational initiation(GO:0002191) |
| 0.0 | 0.9 | GO:0036092 | phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
| 0.0 | 0.1 | GO:0071034 | CUT catabolic process(GO:0071034) CUT metabolic process(GO:0071043) |
| 0.0 | 0.2 | GO:0015742 | alpha-ketoglutarate transport(GO:0015742) |
| 0.0 | 1.2 | GO:0032008 | positive regulation of TOR signaling(GO:0032008) |
| 0.0 | 0.5 | GO:1902895 | positive regulation of pri-miRNA transcription from RNA polymerase II promoter(GO:1902895) |
| 0.0 | 0.9 | GO:0045662 | negative regulation of myoblast differentiation(GO:0045662) |
| 0.0 | 0.1 | GO:0003199 | endocardial cushion to mesenchymal transition involved in heart valve formation(GO:0003199) |
| 0.0 | 1.9 | GO:0006270 | DNA replication initiation(GO:0006270) |
| 0.0 | 0.9 | GO:0048821 | erythrocyte development(GO:0048821) |
| 0.0 | 0.6 | GO:0044342 | type B pancreatic cell proliferation(GO:0044342) |
| 0.0 | 0.7 | GO:0042417 | dopamine metabolic process(GO:0042417) |
| 0.0 | 0.3 | GO:1904380 | endoplasmic reticulum mannose trimming(GO:1904380) |
| 0.0 | 0.3 | GO:0006072 | glycerol-3-phosphate metabolic process(GO:0006072) |
| 0.0 | 0.2 | GO:0036159 | inner dynein arm assembly(GO:0036159) |
| 0.0 | 0.1 | GO:0010387 | COP9 signalosome assembly(GO:0010387) |
| 0.0 | 0.7 | GO:0006370 | 7-methylguanosine mRNA capping(GO:0006370) |
| 0.0 | 1.4 | GO:0006904 | vesicle docking involved in exocytosis(GO:0006904) |
| 0.0 | 0.2 | GO:0051024 | positive regulation of immunoglobulin secretion(GO:0051024) |
| 0.0 | 0.1 | GO:0060364 | uterine wall breakdown(GO:0042704) frontal suture morphogenesis(GO:0060364) |
| 0.0 | 0.8 | GO:0035518 | histone H2A monoubiquitination(GO:0035518) |
| 0.0 | 0.4 | GO:0001682 | tRNA 5'-leader removal(GO:0001682) |
| 0.0 | 0.8 | GO:1902603 | carnitine shuttle(GO:0006853) carnitine transmembrane transport(GO:1902603) |
| 0.0 | 0.3 | GO:0043117 | positive regulation of vascular permeability(GO:0043117) |
| 0.0 | 0.2 | GO:0015798 | myo-inositol transport(GO:0015798) |
| 0.0 | 0.3 | GO:0003197 | endocardial cushion development(GO:0003197) |
| 0.0 | 0.3 | GO:0000463 | maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000463) |
| 0.0 | 0.5 | GO:0015812 | gamma-aminobutyric acid transport(GO:0015812) |
| 0.0 | 0.4 | GO:0021516 | dorsal spinal cord development(GO:0021516) |
| 0.0 | 0.3 | GO:0035020 | regulation of Rac protein signal transduction(GO:0035020) |
| 0.0 | 1.9 | GO:0006968 | cellular defense response(GO:0006968) |
| 0.0 | 0.3 | GO:0060712 | spongiotrophoblast layer development(GO:0060712) |
| 0.0 | 0.8 | GO:0089711 | L-glutamate transmembrane transport(GO:0089711) |
| 0.0 | 0.7 | GO:0035116 | embryonic hindlimb morphogenesis(GO:0035116) |
| 0.0 | 0.1 | GO:0048073 | regulation of eye pigmentation(GO:0048073) |
| 0.0 | 0.2 | GO:0006620 | posttranslational protein targeting to membrane(GO:0006620) |
| 0.0 | 0.1 | GO:0014807 | regulation of somitogenesis(GO:0014807) |
| 0.0 | 0.3 | GO:0030262 | apoptotic nuclear changes(GO:0030262) |
| 0.0 | 0.1 | GO:0086045 | membrane depolarization during AV node cell action potential(GO:0086045) |
| 0.0 | 0.3 | GO:0006069 | ethanol oxidation(GO:0006069) |
| 0.0 | 0.4 | GO:2000036 | regulation of stem cell population maintenance(GO:2000036) |
| 0.0 | 0.1 | GO:0072502 | cellular phosphate ion homeostasis(GO:0030643) cellular divalent inorganic anion homeostasis(GO:0072501) cellular trivalent inorganic anion homeostasis(GO:0072502) |
| 0.0 | 3.5 | GO:0006415 | translational termination(GO:0006415) |
| 0.0 | 0.2 | GO:0010032 | meiotic chromosome condensation(GO:0010032) |
| 0.0 | 0.4 | GO:0045124 | regulation of bone resorption(GO:0045124) |
| 0.0 | 0.2 | GO:0001561 | fatty acid alpha-oxidation(GO:0001561) |
| 0.0 | 0.1 | GO:0023035 | CD40 signaling pathway(GO:0023035) |
| 0.0 | 0.1 | GO:0043129 | surfactant homeostasis(GO:0043129) chemical homeostasis within a tissue(GO:0048875) |
| 0.0 | 0.1 | GO:2000189 | positive regulation of cholesterol homeostasis(GO:2000189) |
| 0.0 | 0.3 | GO:0034427 | nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5'(GO:0034427) |
| 0.0 | 0.5 | GO:0010591 | regulation of lamellipodium assembly(GO:0010591) |
| 0.0 | 0.2 | GO:0051085 | chaperone mediated protein folding requiring cofactor(GO:0051085) |
| 0.0 | 0.2 | GO:0007197 | adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway(GO:0007197) |
| 0.0 | 0.1 | GO:0010566 | regulation of ketone biosynthetic process(GO:0010566) protein demalonylation(GO:0036046) peptidyl-lysine demalonylation(GO:0036047) protein desuccinylation(GO:0036048) peptidyl-lysine desuccinylation(GO:0036049) protein deglutarylation(GO:0061698) peptidyl-lysine deglutarylation(GO:0061699) |
| 0.0 | 0.1 | GO:1903566 | positive regulation of protein localization to cilium(GO:1903566) |
| 0.0 | 0.6 | GO:0072384 | organelle transport along microtubule(GO:0072384) |
| 0.0 | 0.1 | GO:0034721 | histone H3-K4 demethylation, trimethyl-H3-K4-specific(GO:0034721) |
| 0.0 | 2.6 | GO:0030449 | regulation of complement activation(GO:0030449) |
| 0.0 | 0.2 | GO:0036112 | medium-chain fatty-acyl-CoA metabolic process(GO:0036112) |
| 0.0 | 0.2 | GO:0009125 | nucleoside monophosphate catabolic process(GO:0009125) |
| 0.0 | 0.6 | GO:0045773 | positive regulation of axon extension(GO:0045773) |
| 0.0 | 0.1 | GO:0007076 | mitotic chromosome condensation(GO:0007076) |
| 0.0 | 0.6 | GO:0006672 | ceramide metabolic process(GO:0006672) |
| 0.0 | 0.7 | GO:1901028 | regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901028) |
| 0.0 | 0.2 | GO:0051418 | interphase microtubule nucleation by interphase microtubule organizing center(GO:0051415) microtubule nucleation by microtubule organizing center(GO:0051418) |
| 0.0 | 0.3 | GO:0035589 | G-protein coupled purinergic nucleotide receptor signaling pathway(GO:0035589) |
| 0.0 | 0.0 | GO:0016240 | autophagosome docking(GO:0016240) |
| 0.0 | 0.1 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
| 0.0 | 0.4 | GO:0021532 | neural tube patterning(GO:0021532) |
| 0.0 | 0.1 | GO:0044376 | RNA polymerase II complex import to nucleus(GO:0044376) RNA polymerase III complex localization to nucleus(GO:1990022) |
| 0.0 | 0.4 | GO:0010862 | positive regulation of pathway-restricted SMAD protein phosphorylation(GO:0010862) |
| 0.0 | 0.0 | GO:0060836 | lymphatic endothelial cell differentiation(GO:0060836) |
| 0.0 | 0.2 | GO:0032506 | cytokinetic process(GO:0032506) |
| 0.0 | 0.1 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
| 0.0 | 0.1 | GO:0061635 | regulation of protein complex stability(GO:0061635) |
| 0.0 | 0.0 | GO:1904754 | positive regulation of vascular associated smooth muscle cell migration(GO:1904754) |
| 0.0 | 0.4 | GO:0090383 | phagosome acidification(GO:0090383) |
| 0.0 | 0.0 | GO:1902093 | positive regulation of sperm motility(GO:1902093) |
| 0.0 | 0.2 | GO:0019371 | cyclooxygenase pathway(GO:0019371) |
| 0.0 | 0.0 | GO:0014004 | microglia differentiation(GO:0014004) microglia development(GO:0014005) |
| 0.0 | 0.8 | GO:0042273 | ribosomal large subunit biogenesis(GO:0042273) |
| 0.0 | 0.5 | GO:0007041 | lysosomal transport(GO:0007041) |
| 0.0 | 0.0 | GO:0006477 | protein sulfation(GO:0006477) |
| 0.0 | 0.0 | GO:0090403 | oxidative stress-induced premature senescence(GO:0090403) |
Gene overrepresentation in cellular component category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 15.0 | 150.1 | GO:0061689 | tricellular tight junction(GO:0061689) |
| 3.3 | 26.1 | GO:0097451 | glial limiting end-foot(GO:0097451) |
| 3.2 | 19.2 | GO:0070695 | FHF complex(GO:0070695) |
| 2.6 | 13.2 | GO:0019815 | B cell receptor complex(GO:0019815) |
| 2.4 | 12.2 | GO:1990796 | photoreceptor cell terminal bouton(GO:1990796) |
| 2.4 | 81.8 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
| 2.2 | 37.3 | GO:0035253 | ciliary rootlet(GO:0035253) |
| 2.2 | 17.3 | GO:0035976 | AP1 complex(GO:0035976) |
| 1.9 | 7.7 | GO:0097123 | cyclin A1-CDK2 complex(GO:0097123) |
| 1.8 | 16.0 | GO:0033269 | internode region of axon(GO:0033269) |
| 1.8 | 10.6 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
| 1.8 | 21.2 | GO:0043256 | laminin complex(GO:0043256) |
| 1.7 | 44.9 | GO:0005922 | connexon complex(GO:0005922) |
| 1.6 | 6.5 | GO:1990357 | terminal web(GO:1990357) |
| 1.6 | 4.9 | GO:0036338 | viral envelope(GO:0019031) viral membrane(GO:0036338) |
| 1.6 | 11.3 | GO:0097209 | epidermal lamellar body(GO:0097209) |
| 1.6 | 20.6 | GO:0045179 | apical cortex(GO:0045179) |
| 1.5 | 47.3 | GO:0030057 | desmosome(GO:0030057) |
| 1.5 | 5.9 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
| 1.3 | 16.6 | GO:0005915 | zonula adherens(GO:0005915) |
| 1.0 | 1.0 | GO:0034750 | Scrib-APC-beta-catenin complex(GO:0034750) |
| 0.9 | 15.8 | GO:0016600 | flotillin complex(GO:0016600) |
| 0.9 | 13.8 | GO:0033010 | paranodal junction(GO:0033010) |
| 0.9 | 4.6 | GO:0032449 | CBM complex(GO:0032449) |
| 0.9 | 8.0 | GO:0031313 | extrinsic component of endosome membrane(GO:0031313) |
| 0.8 | 11.2 | GO:0036056 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
| 0.8 | 21.0 | GO:0031362 | anchored component of external side of plasma membrane(GO:0031362) |
| 0.7 | 4.4 | GO:0097129 | cyclin D2-CDK4 complex(GO:0097129) |
| 0.7 | 12.3 | GO:0000815 | ESCRT III complex(GO:0000815) |
| 0.7 | 7.7 | GO:0035692 | macrophage migration inhibitory factor receptor complex(GO:0035692) |
| 0.7 | 15.4 | GO:0030056 | hemidesmosome(GO:0030056) |
| 0.7 | 5.3 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
| 0.6 | 1.9 | GO:0008623 | CHRAC(GO:0008623) |
| 0.6 | 115.1 | GO:0070160 | occluding junction(GO:0070160) |
| 0.6 | 2.4 | GO:0017109 | glutamate-cysteine ligase complex(GO:0017109) |
| 0.6 | 1.2 | GO:0000805 | X chromosome(GO:0000805) |
| 0.5 | 27.4 | GO:0030673 | axolemma(GO:0030673) |
| 0.5 | 61.5 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
| 0.5 | 7.3 | GO:0046581 | intercellular canaliculus(GO:0046581) |
| 0.5 | 5.4 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
| 0.5 | 10.1 | GO:0060077 | inhibitory synapse(GO:0060077) |
| 0.5 | 1.4 | GO:0018444 | translation release factor complex(GO:0018444) |
| 0.5 | 2.3 | GO:0001405 | presequence translocase-associated import motor(GO:0001405) |
| 0.4 | 4.5 | GO:0044194 | cytolytic granule(GO:0044194) |
| 0.4 | 6.2 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
| 0.4 | 18.1 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
| 0.4 | 1.8 | GO:0071817 | MMXD complex(GO:0071817) |
| 0.4 | 23.0 | GO:0030131 | clathrin adaptor complex(GO:0030131) |
| 0.4 | 4.3 | GO:0012510 | trans-Golgi network transport vesicle membrane(GO:0012510) |
| 0.4 | 2.1 | GO:0032437 | cuticular plate(GO:0032437) |
| 0.4 | 3.2 | GO:0097418 | neurofibrillary tangle(GO:0097418) |
| 0.4 | 7.7 | GO:0005605 | basal lamina(GO:0005605) |
| 0.4 | 2.4 | GO:0032010 | phagolysosome(GO:0032010) |
| 0.4 | 4.3 | GO:0097427 | microtubule bundle(GO:0097427) |
| 0.4 | 1.6 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
| 0.4 | 12.8 | GO:0034706 | sodium channel complex(GO:0034706) |
| 0.4 | 48.4 | GO:0070821 | tertiary granule membrane(GO:0070821) |
| 0.4 | 29.0 | GO:0045095 | keratin filament(GO:0045095) |
| 0.4 | 1.1 | GO:0000333 | telomerase catalytic core complex(GO:0000333) |
| 0.3 | 1.0 | GO:1990909 | Wnt signalosome(GO:1990909) |
| 0.3 | 2.4 | GO:1990452 | Parkin-FBXW7-Cul1 ubiquitin ligase complex(GO:1990452) |
| 0.3 | 2.7 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
| 0.3 | 6.8 | GO:0005865 | striated muscle thin filament(GO:0005865) |
| 0.3 | 7.6 | GO:0031143 | pseudopodium(GO:0031143) |
| 0.3 | 16.3 | GO:0016328 | lateral plasma membrane(GO:0016328) |
| 0.3 | 38.6 | GO:0072686 | mitotic spindle(GO:0072686) |
| 0.3 | 8.6 | GO:0001533 | cornified envelope(GO:0001533) |
| 0.3 | 3.4 | GO:0072559 | NLRP3 inflammasome complex(GO:0072559) |
| 0.3 | 1.5 | GO:1903349 | omegasome membrane(GO:1903349) |
| 0.3 | 3.2 | GO:0071438 | invadopodium membrane(GO:0071438) |
| 0.3 | 29.3 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
| 0.3 | 0.8 | GO:0000939 | condensed chromosome inner kinetochore(GO:0000939) |
| 0.3 | 6.9 | GO:0031932 | TORC2 complex(GO:0031932) |
| 0.3 | 0.8 | GO:0044609 | DBIRD complex(GO:0044609) |
| 0.3 | 3.5 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
| 0.3 | 7.3 | GO:0001891 | phagocytic cup(GO:0001891) |
| 0.3 | 3.1 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
| 0.3 | 3.3 | GO:0034362 | low-density lipoprotein particle(GO:0034362) |
| 0.3 | 1.3 | GO:0035339 | SPOTS complex(GO:0035339) |
| 0.2 | 1.7 | GO:0098536 | deuterosome(GO:0098536) |
| 0.2 | 11.2 | GO:0005903 | brush border(GO:0005903) |
| 0.2 | 23.3 | GO:0034707 | chloride channel complex(GO:0034707) |
| 0.2 | 0.7 | GO:0098843 | postsynaptic endocytic zone(GO:0098843) |
| 0.2 | 9.5 | GO:0043235 | receptor complex(GO:0043235) |
| 0.2 | 2.0 | GO:0042612 | MHC class I protein complex(GO:0042612) |
| 0.2 | 16.1 | GO:0005771 | multivesicular body(GO:0005771) |
| 0.2 | 4.5 | GO:0005637 | nuclear inner membrane(GO:0005637) |
| 0.2 | 4.2 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
| 0.2 | 0.8 | GO:0002139 | stereocilia coupling link(GO:0002139) |
| 0.2 | 39.4 | GO:0005875 | microtubule associated complex(GO:0005875) |
| 0.2 | 1.2 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
| 0.2 | 3.9 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
| 0.2 | 0.8 | GO:0097057 | TRAF2-GSTP1 complex(GO:0097057) |
| 0.2 | 4.2 | GO:0005861 | troponin complex(GO:0005861) |
| 0.2 | 3.0 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
| 0.2 | 2.5 | GO:0042788 | polysomal ribosome(GO:0042788) |
| 0.2 | 0.8 | GO:0001652 | granular component(GO:0001652) |
| 0.2 | 3.4 | GO:0042611 | MHC protein complex(GO:0042611) |
| 0.2 | 0.6 | GO:0005592 | collagen type XI trimer(GO:0005592) |
| 0.2 | 0.7 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
| 0.2 | 9.6 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
| 0.2 | 3.2 | GO:0031528 | microvillus membrane(GO:0031528) |
| 0.2 | 8.5 | GO:0016235 | aggresome(GO:0016235) |
| 0.2 | 0.8 | GO:0045281 | mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone)(GO:0005749) succinate dehydrogenase complex (ubiquinone)(GO:0045257) respiratory chain complex II(GO:0045273) succinate dehydrogenase complex(GO:0045281) fumarate reductase complex(GO:0045283) |
| 0.2 | 2.7 | GO:0031089 | platelet dense granule lumen(GO:0031089) |
| 0.2 | 29.2 | GO:0001650 | fibrillar center(GO:0001650) |
| 0.1 | 1.3 | GO:0042589 | zymogen granule membrane(GO:0042589) |
| 0.1 | 2.8 | GO:0098576 | lumenal side of membrane(GO:0098576) |
| 0.1 | 1.4 | GO:0042405 | nuclear inclusion body(GO:0042405) |
| 0.1 | 1.1 | GO:0030915 | Smc5-Smc6 complex(GO:0030915) |
| 0.1 | 1.3 | GO:0051233 | spindle midzone(GO:0051233) |
| 0.1 | 0.6 | GO:0043203 | axon hillock(GO:0043203) |
| 0.1 | 0.8 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
| 0.1 | 1.0 | GO:0042721 | mitochondrial inner membrane protein insertion complex(GO:0042721) |
| 0.1 | 0.4 | GO:0005828 | kinetochore microtubule(GO:0005828) |
| 0.1 | 1.8 | GO:0061700 | GATOR2 complex(GO:0061700) |
| 0.1 | 5.2 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
| 0.1 | 2.2 | GO:0000780 | condensed nuclear chromosome, centromeric region(GO:0000780) |
| 0.1 | 11.2 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
| 0.1 | 13.1 | GO:0005604 | basement membrane(GO:0005604) |
| 0.1 | 5.5 | GO:0016592 | mediator complex(GO:0016592) |
| 0.1 | 0.6 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
| 0.1 | 0.8 | GO:0071012 | catalytic step 1 spliceosome(GO:0071012) |
| 0.1 | 0.2 | GO:0032021 | NELF complex(GO:0032021) |
| 0.1 | 1.1 | GO:0031390 | Ctf18 RFC-like complex(GO:0031390) |
| 0.1 | 1.6 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
| 0.1 | 0.7 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
| 0.1 | 1.1 | GO:0097470 | ribbon synapse(GO:0097470) |
| 0.1 | 1.0 | GO:0005921 | gap junction(GO:0005921) |
| 0.1 | 0.7 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
| 0.1 | 0.3 | GO:0005745 | m-AAA complex(GO:0005745) |
| 0.1 | 2.7 | GO:0002102 | podosome(GO:0002102) |
| 0.1 | 14.5 | GO:0048770 | melanosome(GO:0042470) pigment granule(GO:0048770) |
| 0.1 | 12.1 | GO:0000118 | histone deacetylase complex(GO:0000118) |
| 0.1 | 0.8 | GO:0019907 | cyclin-dependent protein kinase activating kinase holoenzyme complex(GO:0019907) |
| 0.1 | 11.6 | GO:0045111 | intermediate filament cytoskeleton(GO:0045111) |
| 0.1 | 9.0 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
| 0.1 | 99.9 | GO:0016604 | nuclear body(GO:0016604) |
| 0.1 | 0.3 | GO:1990716 | axonemal central apparatus(GO:1990716) |
| 0.1 | 0.5 | GO:0002079 | inner acrosomal membrane(GO:0002079) |
| 0.1 | 8.2 | GO:0016529 | sarcoplasmic reticulum(GO:0016529) |
| 0.1 | 1.0 | GO:0031298 | replication fork protection complex(GO:0031298) |
| 0.1 | 0.3 | GO:0055087 | Ski complex(GO:0055087) |
| 0.1 | 0.3 | GO:1990742 | microvesicle(GO:1990742) |
| 0.1 | 0.8 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
| 0.1 | 1.0 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
| 0.1 | 1.9 | GO:0005639 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) |
| 0.1 | 9.5 | GO:0035578 | azurophil granule lumen(GO:0035578) |
| 0.1 | 3.0 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
| 0.1 | 0.5 | GO:1990682 | CSF1-CSF1R complex(GO:1990682) |
| 0.1 | 0.8 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
| 0.1 | 0.9 | GO:0072546 | ER membrane protein complex(GO:0072546) |
| 0.1 | 0.7 | GO:0071541 | eukaryotic translation initiation factor 3 complex, eIF3m(GO:0071541) |
| 0.1 | 0.4 | GO:0036021 | endolysosome lumen(GO:0036021) |
| 0.1 | 0.4 | GO:0032280 | symmetric synapse(GO:0032280) |
| 0.1 | 1.6 | GO:0030660 | Golgi-associated vesicle membrane(GO:0030660) |
| 0.1 | 1.0 | GO:0031594 | neuromuscular junction(GO:0031594) |
| 0.1 | 1.0 | GO:0097433 | dense body(GO:0097433) |
| 0.1 | 1.0 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
| 0.1 | 0.2 | GO:0043196 | varicosity(GO:0043196) |
| 0.1 | 0.6 | GO:0016012 | dystroglycan complex(GO:0016011) sarcoglycan complex(GO:0016012) |
| 0.1 | 3.9 | GO:0005776 | autophagosome(GO:0005776) |
| 0.1 | 9.8 | GO:0032587 | ruffle membrane(GO:0032587) |
| 0.1 | 0.3 | GO:0061617 | MICOS complex(GO:0061617) |
| 0.1 | 0.3 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
| 0.1 | 0.4 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
| 0.1 | 0.8 | GO:0036454 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) |
| 0.1 | 0.7 | GO:0070938 | contractile ring(GO:0070938) |
| 0.1 | 1.7 | GO:0016514 | SWI/SNF complex(GO:0016514) |
| 0.1 | 0.9 | GO:0071203 | WASH complex(GO:0071203) |
| 0.1 | 0.1 | GO:0097443 | sorting endosome(GO:0097443) |
| 0.1 | 0.6 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
| 0.1 | 0.3 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
| 0.1 | 0.4 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
| 0.1 | 10.3 | GO:0005911 | cell-cell junction(GO:0005911) |
| 0.1 | 0.4 | GO:0071004 | U2-type prespliceosome(GO:0071004) |
| 0.1 | 0.2 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
| 0.1 | 0.7 | GO:0045275 | mitochondrial respiratory chain complex III(GO:0005750) respiratory chain complex III(GO:0045275) |
| 0.1 | 7.6 | GO:0055037 | recycling endosome(GO:0055037) |
| 0.0 | 0.6 | GO:0043198 | dendritic shaft(GO:0043198) |
| 0.0 | 0.1 | GO:0002178 | palmitoyltransferase complex(GO:0002178) |
| 0.0 | 276.3 | GO:0016021 | integral component of membrane(GO:0016021) |
| 0.0 | 0.5 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
| 0.0 | 0.4 | GO:0005655 | nucleolar ribonuclease P complex(GO:0005655) |
| 0.0 | 0.3 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
| 0.0 | 0.1 | GO:0033263 | CORVET complex(GO:0033263) |
| 0.0 | 0.1 | GO:0042588 | zymogen granule(GO:0042588) |
| 0.0 | 0.6 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
| 0.0 | 1.1 | GO:0005763 | organellar small ribosomal subunit(GO:0000314) mitochondrial small ribosomal subunit(GO:0005763) |
| 0.0 | 0.7 | GO:0044452 | nucleolar part(GO:0044452) |
| 0.0 | 0.2 | GO:0005947 | mitochondrial alpha-ketoglutarate dehydrogenase complex(GO:0005947) |
| 0.0 | 0.6 | GO:0030670 | phagocytic vesicle membrane(GO:0030670) |
| 0.0 | 0.4 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
| 0.0 | 3.3 | GO:0045121 | membrane raft(GO:0045121) membrane microdomain(GO:0098857) |
| 0.0 | 0.8 | GO:0030687 | preribosome, large subunit precursor(GO:0030687) |
| 0.0 | 0.4 | GO:0005849 | mRNA cleavage factor complex(GO:0005849) |
| 0.0 | 0.3 | GO:0071141 | SMAD protein complex(GO:0071141) |
| 0.0 | 0.8 | GO:0099501 | synaptic vesicle membrane(GO:0030672) exocytic vesicle membrane(GO:0099501) |
| 0.0 | 3.1 | GO:0101002 | ficolin-1-rich granule(GO:0101002) ficolin-1-rich granule lumen(GO:1904813) |
| 0.0 | 0.3 | GO:0045254 | pyruvate dehydrogenase complex(GO:0045254) |
| 0.0 | 0.2 | GO:0035102 | PRC1 complex(GO:0035102) |
| 0.0 | 0.1 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
| 0.0 | 0.1 | GO:0008622 | epsilon DNA polymerase complex(GO:0008622) |
| 0.0 | 0.1 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
| 0.0 | 0.1 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
| 0.0 | 0.2 | GO:0032039 | integrator complex(GO:0032039) |
| 0.0 | 0.8 | GO:0001750 | photoreceptor outer segment(GO:0001750) |
| 0.0 | 1.1 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
| 0.0 | 0.0 | GO:1990777 | plasma lipoprotein particle(GO:0034358) lipoprotein particle(GO:1990777) |
| 0.0 | 2.3 | GO:0010008 | endosome membrane(GO:0010008) |
| 0.0 | 1.2 | GO:0034399 | nuclear periphery(GO:0034399) |
| 0.0 | 0.1 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
Gene overrepresentation in molecular function category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 5.1 | 15.4 | GO:0004605 | phosphatidate cytidylyltransferase activity(GO:0004605) |
| 5.1 | 41.0 | GO:0086083 | cell adhesive protein binding involved in bundle of His cell-Purkinje myocyte communication(GO:0086083) |
| 4.0 | 12.1 | GO:1902271 | D3 vitamins binding(GO:1902271) |
| 2.8 | 16.9 | GO:0038062 | protein tyrosine kinase collagen receptor activity(GO:0038062) |
| 2.5 | 29.6 | GO:0038132 | neuregulin binding(GO:0038132) |
| 2.4 | 21.9 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
| 2.4 | 7.2 | GO:0005055 | laminin receptor activity(GO:0005055) |
| 2.3 | 16.4 | GO:0035662 | Toll-like receptor 4 binding(GO:0035662) |
| 2.2 | 24.7 | GO:0102338 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
| 2.1 | 10.7 | GO:0034040 | lipid-transporting ATPase activity(GO:0034040) |
| 2.1 | 26.8 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
| 2.0 | 5.9 | GO:1904928 | coreceptor activity involved in canonical Wnt signaling pathway(GO:1904928) |
| 1.8 | 9.1 | GO:0050473 | arachidonate 15-lipoxygenase activity(GO:0050473) |
| 1.8 | 10.7 | GO:1990254 | keratin filament binding(GO:1990254) |
| 1.7 | 6.8 | GO:0002060 | purine nucleobase binding(GO:0002060) |
| 1.7 | 5.1 | GO:0008859 | exoribonuclease II activity(GO:0008859) |
| 1.6 | 4.9 | GO:0043682 | copper-exporting ATPase activity(GO:0004008) copper-transporting ATPase activity(GO:0043682) |
| 1.6 | 4.9 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
| 1.6 | 20.6 | GO:0042608 | T cell receptor binding(GO:0042608) |
| 1.6 | 14.3 | GO:0070097 | delta-catenin binding(GO:0070097) |
| 1.6 | 9.5 | GO:0042392 | sphingosine-1-phosphate phosphatase activity(GO:0042392) |
| 1.6 | 15.7 | GO:0071253 | connexin binding(GO:0071253) |
| 1.5 | 10.4 | GO:0016416 | O-palmitoyltransferase activity(GO:0016416) |
| 1.4 | 4.3 | GO:0030348 | syntaxin-3 binding(GO:0030348) |
| 1.4 | 4.3 | GO:0005150 | interleukin-1, Type I receptor binding(GO:0005150) |
| 1.4 | 4.2 | GO:0003845 | 11-beta-hydroxysteroid dehydrogenase [NAD(P)] activity(GO:0003845) |
| 1.4 | 42.7 | GO:0098641 | cadherin binding involved in cell-cell adhesion(GO:0098641) |
| 1.4 | 12.3 | GO:0050682 | AF-2 domain binding(GO:0050682) |
| 1.3 | 10.6 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
| 1.3 | 3.9 | GO:0004566 | beta-glucuronidase activity(GO:0004566) heparanase activity(GO:0030305) |
| 1.3 | 20.4 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
| 1.3 | 8.8 | GO:0070891 | lipoteichoic acid binding(GO:0070891) |
| 1.2 | 6.2 | GO:0015119 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
| 1.2 | 3.6 | GO:0097604 | temperature-gated cation channel activity(GO:0097604) |
| 1.2 | 3.5 | GO:0097363 | protein O-GlcNAc transferase activity(GO:0097363) |
| 1.2 | 3.5 | GO:0047223 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase activity(GO:0047223) |
| 1.2 | 3.5 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
| 1.1 | 8.6 | GO:0001875 | lipopolysaccharide receptor activity(GO:0001875) |
| 1.1 | 19.4 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
| 1.1 | 10.6 | GO:0004630 | phospholipase D activity(GO:0004630) |
| 1.1 | 4.2 | GO:0015154 | sucrose:proton symporter activity(GO:0008506) sucrose transmembrane transporter activity(GO:0008515) disaccharide transmembrane transporter activity(GO:0015154) oligosaccharide transmembrane transporter activity(GO:0015157) |
| 1.0 | 4.0 | GO:0016524 | latrotoxin receptor activity(GO:0016524) |
| 1.0 | 13.9 | GO:0035325 | Toll-like receptor binding(GO:0035325) |
| 0.9 | 15.8 | GO:0001161 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) intronic transcription regulatory region DNA binding(GO:0044213) |
| 0.9 | 10.1 | GO:0098632 | protein binding involved in cell-cell adhesion(GO:0098632) |
| 0.9 | 7.1 | GO:0019534 | toxin transporter activity(GO:0019534) |
| 0.9 | 2.7 | GO:0004939 | beta-adrenergic receptor activity(GO:0004939) |
| 0.9 | 4.4 | GO:0003976 | UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity(GO:0003976) |
| 0.9 | 4.4 | GO:0004910 | interleukin-1, Type II, blocking receptor activity(GO:0004910) |
| 0.9 | 5.2 | GO:0031735 | CCR10 chemokine receptor binding(GO:0031735) |
| 0.9 | 28.8 | GO:0019198 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
| 0.9 | 12.2 | GO:0050544 | arachidonic acid binding(GO:0050544) |
| 0.9 | 6.1 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
| 0.9 | 13.8 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
| 0.8 | 0.8 | GO:0086006 | voltage-gated sodium channel activity involved in cardiac muscle cell action potential(GO:0086006) voltage-gated sodium channel activity involved in Purkinje myocyte action potential(GO:0086062) |
| 0.8 | 16.5 | GO:0031078 | histone deacetylase activity (H3-K14 specific)(GO:0031078) NAD-dependent histone deacetylase activity (H3-K14 specific)(GO:0032041) |
| 0.8 | 3.3 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
| 0.8 | 2.5 | GO:0005499 | vitamin D binding(GO:0005499) |
| 0.8 | 11.2 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
| 0.8 | 3.1 | GO:0047192 | 1-alkylglycerophosphocholine O-acetyltransferase activity(GO:0047192) |
| 0.8 | 21.7 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
| 0.8 | 2.3 | GO:0008401 | retinoic acid 4-hydroxylase activity(GO:0008401) |
| 0.7 | 11.2 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
| 0.7 | 14.9 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
| 0.7 | 53.4 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
| 0.7 | 10.8 | GO:0042834 | peptidoglycan binding(GO:0042834) |
| 0.7 | 27.4 | GO:0042056 | chemoattractant activity(GO:0042056) |
| 0.7 | 45.6 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
| 0.7 | 43.3 | GO:0042379 | chemokine receptor binding(GO:0042379) |
| 0.7 | 2.0 | GO:0031755 | endothelial differentiation G-protein coupled receptor binding(GO:0031753) Edg-2 lysophosphatidic acid receptor binding(GO:0031755) |
| 0.6 | 1.9 | GO:0008903 | hydroxypyruvate isomerase activity(GO:0008903) |
| 0.6 | 4.3 | GO:0015198 | oligopeptide transporter activity(GO:0015198) |
| 0.6 | 47.7 | GO:0019894 | kinesin binding(GO:0019894) |
| 0.6 | 15.3 | GO:0038191 | neuropilin binding(GO:0038191) |
| 0.6 | 5.5 | GO:0047623 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
| 0.6 | 3.6 | GO:0003835 | beta-galactoside alpha-2,6-sialyltransferase activity(GO:0003835) |
| 0.6 | 2.4 | GO:0004357 | glutamate-cysteine ligase activity(GO:0004357) |
| 0.6 | 1.8 | GO:0015389 | pyrimidine- and adenine-specific:sodium symporter activity(GO:0015389) |
| 0.6 | 5.9 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
| 0.6 | 26.0 | GO:0000146 | microfilament motor activity(GO:0000146) |
| 0.6 | 1.7 | GO:0003858 | 3-hydroxybutyrate dehydrogenase activity(GO:0003858) |
| 0.6 | 8.0 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
| 0.6 | 2.9 | GO:0046899 | nucleoside triphosphate adenylate kinase activity(GO:0046899) |
| 0.6 | 0.6 | GO:0005350 | pyrimidine nucleobase transmembrane transporter activity(GO:0005350) |
| 0.5 | 2.2 | GO:0004583 | dolichyl-phosphate-glucose-glycolipid alpha-glucosyltransferase activity(GO:0004583) |
| 0.5 | 4.3 | GO:0015184 | L-cystine transmembrane transporter activity(GO:0015184) |
| 0.5 | 2.6 | GO:0003945 | N-acetyllactosamine synthase activity(GO:0003945) |
| 0.5 | 2.1 | GO:0004329 | formate-tetrahydrofolate ligase activity(GO:0004329) |
| 0.5 | 14.1 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
| 0.5 | 2.1 | GO:0008426 | protein kinase C inhibitor activity(GO:0008426) |
| 0.5 | 19.2 | GO:0019707 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) protein-cysteine S-acyltransferase activity(GO:0019707) |
| 0.5 | 4.1 | GO:0051425 | PTB domain binding(GO:0051425) |
| 0.5 | 8.1 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
| 0.5 | 14.1 | GO:0005112 | Notch binding(GO:0005112) |
| 0.5 | 1.5 | GO:0008476 | protein-tyrosine sulfotransferase activity(GO:0008476) |
| 0.5 | 4.0 | GO:0005332 | gamma-aminobutyric acid:sodium symporter activity(GO:0005332) |
| 0.5 | 2.0 | GO:0022865 | transmembrane electron transfer carrier(GO:0022865) |
| 0.5 | 2.0 | GO:0003883 | CTP synthase activity(GO:0003883) |
| 0.5 | 6.4 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
| 0.5 | 5.3 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
| 0.5 | 8.7 | GO:0097016 | L27 domain binding(GO:0097016) |
| 0.5 | 1.4 | GO:0047025 | 3-oxoacyl-[acyl-carrier-protein] reductase (NADH) activity(GO:0047025) |
| 0.5 | 3.3 | GO:0001517 | N-acetylglucosamine 6-O-sulfotransferase activity(GO:0001517) |
| 0.5 | 6.9 | GO:0008503 | benzodiazepine receptor activity(GO:0008503) |
| 0.5 | 5.5 | GO:0022889 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
| 0.5 | 1.4 | GO:0000099 | sulfur amino acid transmembrane transporter activity(GO:0000099) |
| 0.5 | 18.5 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
| 0.4 | 1.8 | GO:0034046 | poly(G) binding(GO:0034046) |
| 0.4 | 2.2 | GO:0016749 | 5-aminolevulinate synthase activity(GO:0003870) N-succinyltransferase activity(GO:0016749) |
| 0.4 | 1.3 | GO:0051377 | mannose-ethanolamine phosphotransferase activity(GO:0051377) |
| 0.4 | 1.3 | GO:0060175 | brain-derived neurotrophic factor-activated receptor activity(GO:0060175) |
| 0.4 | 19.9 | GO:0003785 | actin monomer binding(GO:0003785) |
| 0.4 | 4.3 | GO:0001727 | lipid kinase activity(GO:0001727) |
| 0.4 | 2.5 | GO:0050294 | steroid sulfotransferase activity(GO:0050294) |
| 0.4 | 2.1 | GO:0019238 | cyclohydrolase activity(GO:0019238) |
| 0.4 | 3.3 | GO:0071936 | coreceptor activity involved in Wnt signaling pathway(GO:0071936) |
| 0.4 | 2.3 | GO:0045545 | syndecan binding(GO:0045545) |
| 0.4 | 1.9 | GO:0016971 | flavin-linked sulfhydryl oxidase activity(GO:0016971) |
| 0.4 | 3.1 | GO:1903136 | cuprous ion binding(GO:1903136) |
| 0.4 | 3.5 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
| 0.4 | 14.2 | GO:0005109 | frizzled binding(GO:0005109) |
| 0.4 | 7.1 | GO:0043560 | insulin receptor substrate binding(GO:0043560) |
| 0.4 | 1.1 | GO:0052854 | (S)-2-hydroxy-acid oxidase activity(GO:0003973) very-long-chain-(S)-2-hydroxy-acid oxidase activity(GO:0052852) long-chain-(S)-2-hydroxy-long-chain-acid oxidase activity(GO:0052853) medium-chain-(S)-2-hydroxy-acid oxidase activity(GO:0052854) |
| 0.4 | 7.0 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
| 0.4 | 6.9 | GO:0017110 | nucleoside-diphosphatase activity(GO:0017110) |
| 0.4 | 1.4 | GO:0047685 | amine sulfotransferase activity(GO:0047685) |
| 0.3 | 2.1 | GO:0034597 | phosphatidylinositol-3,4-bisphosphate 4-phosphatase activity(GO:0016316) inositol-1,3,4-trisphosphate 4-phosphatase activity(GO:0017161) phosphatidylinositol-4,5-bisphosphate 4-phosphatase activity(GO:0034597) inositol-3,4-bisphosphate 4-phosphatase activity(GO:0052828) |
| 0.3 | 1.0 | GO:0000035 | acyl binding(GO:0000035) |
| 0.3 | 4.4 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
| 0.3 | 2.4 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
| 0.3 | 1.3 | GO:0050816 | phosphothreonine binding(GO:0050816) |
| 0.3 | 1.7 | GO:0033906 | hyaluronoglucuronidase activity(GO:0033906) |
| 0.3 | 1.0 | GO:0004052 | arachidonate 12-lipoxygenase activity(GO:0004052) |
| 0.3 | 1.7 | GO:0042015 | interleukin-20 binding(GO:0042015) |
| 0.3 | 7.0 | GO:0030159 | receptor signaling complex scaffold activity(GO:0030159) |
| 0.3 | 3.0 | GO:0035252 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
| 0.3 | 0.7 | GO:0019959 | interleukin-8 binding(GO:0019959) |
| 0.3 | 1.0 | GO:0000033 | alpha-1,3-mannosyltransferase activity(GO:0000033) |
| 0.3 | 2.6 | GO:0090599 | alpha-glucosidase activity(GO:0090599) |
| 0.3 | 10.0 | GO:0004707 | MAP kinase activity(GO:0004707) |
| 0.3 | 3.2 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
| 0.3 | 1.3 | GO:0050692 | DBD domain binding(GO:0050692) |
| 0.3 | 1.6 | GO:0004809 | tRNA (guanine-N2-)-methyltransferase activity(GO:0004809) |
| 0.3 | 1.6 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
| 0.3 | 1.9 | GO:0010465 | nerve growth factor receptor activity(GO:0010465) |
| 0.3 | 42.0 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
| 0.3 | 0.9 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
| 0.3 | 10.9 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
| 0.3 | 10.5 | GO:0005031 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
| 0.3 | 1.8 | GO:0017060 | 3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase activity(GO:0017060) |
| 0.3 | 4.2 | GO:0031014 | troponin T binding(GO:0031014) |
| 0.3 | 1.2 | GO:0070546 | L-phenylalanine aminotransferase activity(GO:0070546) |
| 0.3 | 1.7 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
| 0.3 | 1.2 | GO:0016495 | C-X3-C chemokine receptor activity(GO:0016495) |
| 0.3 | 1.2 | GO:0051538 | 3 iron, 4 sulfur cluster binding(GO:0051538) |
| 0.3 | 0.9 | GO:0009383 | rRNA (cytosine-C5-)-methyltransferase activity(GO:0009383) |
| 0.3 | 0.3 | GO:0016534 | cyclin-dependent protein kinase 5 activator activity(GO:0016534) |
| 0.3 | 1.4 | GO:0045505 | dynein intermediate chain binding(GO:0045505) |
| 0.3 | 0.8 | GO:0052726 | inositol tetrakisphosphate 1-kinase activity(GO:0047325) inositol-1,3,4-trisphosphate 6-kinase activity(GO:0052725) inositol-1,3,4-trisphosphate 5-kinase activity(GO:0052726) inositol-1,3,4,5,6-pentakisphosphate 1-phosphatase activity(GO:0052825) inositol-1,3,4,6-tetrakisphosphate 6-phosphatase activity(GO:0052830) inositol-1,3,4,6-tetrakisphosphate 1-phosphatase activity(GO:0052831) inositol-3,4,6-trisphosphate 1-kinase activity(GO:0052835) |
| 0.3 | 31.3 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
| 0.3 | 1.1 | GO:0034186 | apolipoprotein receptor activity(GO:0030226) apolipoprotein A-I binding(GO:0034186) |
| 0.3 | 99.6 | GO:0003729 | mRNA binding(GO:0003729) poly(A) RNA binding(GO:0044822) |
| 0.3 | 2.5 | GO:0038036 | sphingosine-1-phosphate receptor activity(GO:0038036) |
| 0.3 | 2.7 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
| 0.3 | 1.1 | GO:0004102 | choline O-acetyltransferase activity(GO:0004102) |
| 0.3 | 1.4 | GO:0008160 | protein tyrosine phosphatase activator activity(GO:0008160) |
| 0.3 | 0.8 | GO:0035730 | S-nitrosoglutathione binding(GO:0035730) dinitrosyl-iron complex binding(GO:0035731) |
| 0.3 | 8.8 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
| 0.3 | 2.1 | GO:0048273 | mitogen-activated protein kinase p38 binding(GO:0048273) |
| 0.3 | 0.8 | GO:0050509 | N-acetylglucosaminyl-proteoglycan 4-beta-glucuronosyltransferase activity(GO:0050509) |
| 0.3 | 4.4 | GO:0005243 | gap junction channel activity(GO:0005243) |
| 0.3 | 1.0 | GO:0003974 | UDP-N-acetylglucosamine 4-epimerase activity(GO:0003974) UDP-glucose 4-epimerase activity(GO:0003978) |
| 0.3 | 2.0 | GO:0052833 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
| 0.3 | 5.3 | GO:0001087 | transcription factor activity, sequence-specific DNA binding, RNA polymerase recruiting(GO:0001011) transcription factor activity, TFIIB-class binding(GO:0001087) |
| 0.3 | 1.5 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
| 0.3 | 0.8 | GO:0031862 | prostanoid receptor binding(GO:0031862) |
| 0.2 | 0.7 | GO:0016503 | pheromone receptor activity(GO:0016503) |
| 0.2 | 2.0 | GO:0046979 | TAP2 binding(GO:0046979) |
| 0.2 | 7.3 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
| 0.2 | 3.4 | GO:0032395 | MHC class II receptor activity(GO:0032395) |
| 0.2 | 2.9 | GO:0050998 | nitric-oxide synthase binding(GO:0050998) |
| 0.2 | 1.2 | GO:0016509 | long-chain-3-hydroxyacyl-CoA dehydrogenase activity(GO:0016509) |
| 0.2 | 3.3 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
| 0.2 | 0.7 | GO:0008336 | gamma-butyrobetaine dioxygenase activity(GO:0008336) |
| 0.2 | 0.9 | GO:0050211 | procollagen galactosyltransferase activity(GO:0050211) |
| 0.2 | 0.7 | GO:1904455 | ubiquitin-specific protease activity involved in negative regulation of ERAD pathway(GO:1904455) |
| 0.2 | 1.6 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
| 0.2 | 6.8 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
| 0.2 | 1.4 | GO:0016802 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
| 0.2 | 7.8 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
| 0.2 | 13.3 | GO:0004864 | protein phosphatase inhibitor activity(GO:0004864) |
| 0.2 | 2.7 | GO:0001135 | transcription factor activity, RNA polymerase II transcription factor recruiting(GO:0001135) |
| 0.2 | 0.9 | GO:0004515 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
| 0.2 | 4.0 | GO:0009931 | calcium-dependent protein serine/threonine kinase activity(GO:0009931) |
| 0.2 | 66.4 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
| 0.2 | 1.1 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
| 0.2 | 1.5 | GO:0003747 | translation release factor activity(GO:0003747) translation termination factor activity(GO:0008079) |
| 0.2 | 3.6 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
| 0.2 | 1.0 | GO:0000179 | rRNA (adenine-N6,N6-)-dimethyltransferase activity(GO:0000179) |
| 0.2 | 3.7 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
| 0.2 | 2.7 | GO:0000182 | rDNA binding(GO:0000182) |
| 0.2 | 3.9 | GO:0001054 | RNA polymerase I activity(GO:0001054) |
| 0.2 | 2.5 | GO:0050786 | RAGE receptor binding(GO:0050786) |
| 0.2 | 8.0 | GO:0032947 | protein complex scaffold(GO:0032947) |
| 0.2 | 1.6 | GO:0005052 | peroxisome matrix targeting signal-1 binding(GO:0005052) |
| 0.2 | 2.7 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
| 0.2 | 14.7 | GO:0097110 | scaffold protein binding(GO:0097110) |
| 0.2 | 0.8 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
| 0.2 | 1.4 | GO:0034235 | GPI anchor binding(GO:0034235) |
| 0.2 | 2.0 | GO:0019215 | intermediate filament binding(GO:0019215) |
| 0.2 | 2.0 | GO:0016725 | oxidoreductase activity, acting on CH or CH2 groups(GO:0016725) |
| 0.2 | 3.7 | GO:0032454 | histone demethylase activity (H3-K9 specific)(GO:0032454) |
| 0.2 | 7.2 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
| 0.2 | 1.2 | GO:0048101 | calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity(GO:0048101) |
| 0.2 | 1.9 | GO:0001042 | RNA polymerase I core binding(GO:0001042) |
| 0.2 | 1.0 | GO:0047280 | nicotinamide phosphoribosyltransferase activity(GO:0047280) |
| 0.2 | 1.3 | GO:0008310 | single-stranded DNA 3'-5' exodeoxyribonuclease activity(GO:0008310) |
| 0.2 | 3.8 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
| 0.2 | 5.2 | GO:0031489 | myosin V binding(GO:0031489) |
| 0.2 | 1.9 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
| 0.2 | 29.5 | GO:0008201 | heparin binding(GO:0008201) |
| 0.2 | 0.7 | GO:0098808 | mRNA cap binding(GO:0098808) |
| 0.2 | 1.5 | GO:0001948 | glycoprotein binding(GO:0001948) |
| 0.2 | 1.4 | GO:0047144 | 2-acylglycerol-3-phosphate O-acyltransferase activity(GO:0047144) |
| 0.2 | 2.0 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
| 0.2 | 6.1 | GO:0004385 | guanylate kinase activity(GO:0004385) |
| 0.2 | 0.4 | GO:1990763 | arrestin family protein binding(GO:1990763) |
| 0.2 | 7.3 | GO:0043236 | laminin binding(GO:0043236) |
| 0.2 | 7.8 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
| 0.2 | 2.7 | GO:0008199 | ferric iron binding(GO:0008199) |
| 0.2 | 0.7 | GO:0031802 | type 5 metabotropic glutamate receptor binding(GO:0031802) |
| 0.2 | 0.7 | GO:0004882 | androgen receptor activity(GO:0004882) |
| 0.2 | 1.2 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
| 0.2 | 0.7 | GO:0004925 | prolactin receptor activity(GO:0004925) |
| 0.2 | 0.9 | GO:0046964 | 3'-phosphoadenosine 5'-phosphosulfate transmembrane transporter activity(GO:0046964) |
| 0.2 | 4.1 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
| 0.2 | 1.5 | GO:0008440 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) inositol trisphosphate kinase activity(GO:0051766) |
| 0.2 | 0.7 | GO:0005497 | androgen binding(GO:0005497) |
| 0.2 | 3.8 | GO:0070330 | aromatase activity(GO:0070330) |
| 0.2 | 0.7 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
| 0.2 | 5.1 | GO:0030553 | cGMP binding(GO:0030553) |
| 0.2 | 0.5 | GO:0003831 | beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity(GO:0003831) |
| 0.2 | 2.0 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
| 0.2 | 1.2 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
| 0.2 | 0.5 | GO:0061649 | ubiquitinated histone binding(GO:0061649) |
| 0.2 | 7.3 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
| 0.2 | 1.8 | GO:0016723 | oxidoreductase activity, oxidizing metal ions, NAD or NADP as acceptor(GO:0016723) |
| 0.2 | 0.7 | GO:0050253 | retinyl-palmitate esterase activity(GO:0050253) |
| 0.2 | 5.2 | GO:0034237 | protein kinase A regulatory subunit binding(GO:0034237) |
| 0.2 | 1.8 | GO:0043139 | 5'-3' DNA helicase activity(GO:0043139) |
| 0.2 | 1.4 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
| 0.2 | 25.6 | GO:0017124 | SH3 domain binding(GO:0017124) |
| 0.2 | 0.3 | GO:0008177 | succinate dehydrogenase (ubiquinone) activity(GO:0008177) |
| 0.2 | 0.9 | GO:0035256 | G-protein coupled glutamate receptor binding(GO:0035256) |
| 0.2 | 0.3 | GO:0019912 | cyclin-dependent protein kinase activating kinase activity(GO:0019912) |
| 0.2 | 67.4 | GO:0045296 | cadherin binding(GO:0045296) |
| 0.2 | 0.6 | GO:0033188 | sphingomyelin synthase activity(GO:0033188) ceramide cholinephosphotransferase activity(GO:0047493) |
| 0.2 | 0.8 | GO:0016708 | nitric oxide dioxygenase activity(GO:0008941) oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of two atoms of oxygen into one donor(GO:0016708) |
| 0.2 | 0.6 | GO:0098770 | FBXO family protein binding(GO:0098770) |
| 0.2 | 0.5 | GO:0005011 | macrophage colony-stimulating factor receptor activity(GO:0005011) |
| 0.2 | 2.0 | GO:0005347 | adenine nucleotide transmembrane transporter activity(GO:0000295) purine ribonucleotide transmembrane transporter activity(GO:0005346) ATP transmembrane transporter activity(GO:0005347) ADP transmembrane transporter activity(GO:0015217) |
| 0.2 | 2.1 | GO:0022820 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
| 0.2 | 0.5 | GO:0045131 | pre-mRNA branch point binding(GO:0045131) |
| 0.2 | 1.2 | GO:0032217 | riboflavin transporter activity(GO:0032217) |
| 0.1 | 0.4 | GO:0033754 | indoleamine 2,3-dioxygenase activity(GO:0033754) |
| 0.1 | 2.8 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
| 0.1 | 0.7 | GO:0004663 | Rab geranylgeranyltransferase activity(GO:0004663) |
| 0.1 | 2.3 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
| 0.1 | 0.4 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
| 0.1 | 0.9 | GO:0045029 | UDP-activated nucleotide receptor activity(GO:0045029) |
| 0.1 | 1.1 | GO:0061665 | SUMO ligase activity(GO:0061665) |
| 0.1 | 3.5 | GO:0035497 | cAMP response element binding(GO:0035497) |
| 0.1 | 2.2 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
| 0.1 | 3.1 | GO:0016505 | peptidase activator activity involved in apoptotic process(GO:0016505) |
| 0.1 | 0.8 | GO:0003872 | 6-phosphofructokinase activity(GO:0003872) |
| 0.1 | 1.1 | GO:0004996 | thyroid-stimulating hormone receptor activity(GO:0004996) |
| 0.1 | 13.6 | GO:0003727 | single-stranded RNA binding(GO:0003727) |
| 0.1 | 0.9 | GO:0016618 | hydroxypyruvate reductase activity(GO:0016618) glyoxylate reductase (NADP) activity(GO:0030267) |
| 0.1 | 0.9 | GO:0034618 | arginine binding(GO:0034618) |
| 0.1 | 0.4 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
| 0.1 | 1.5 | GO:0015232 | heme transporter activity(GO:0015232) |
| 0.1 | 1.3 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
| 0.1 | 1.3 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
| 0.1 | 15.3 | GO:0019905 | syntaxin binding(GO:0019905) |
| 0.1 | 8.0 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
| 0.1 | 3.4 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
| 0.1 | 0.2 | GO:0031893 | vasopressin receptor binding(GO:0031893) |
| 0.1 | 1.1 | GO:0033170 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
| 0.1 | 2.5 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
| 0.1 | 1.1 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
| 0.1 | 3.2 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
| 0.1 | 0.8 | GO:0016167 | glial cell-derived neurotrophic factor receptor activity(GO:0016167) |
| 0.1 | 7.9 | GO:0001102 | RNA polymerase II activating transcription factor binding(GO:0001102) |
| 0.1 | 0.8 | GO:0035174 | histone serine kinase activity(GO:0035174) |
| 0.1 | 0.3 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
| 0.1 | 5.5 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
| 0.1 | 0.7 | GO:0004489 | methylenetetrahydrofolate reductase (NAD(P)H) activity(GO:0004489) |
| 0.1 | 0.7 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
| 0.1 | 0.3 | GO:0004766 | spermidine synthase activity(GO:0004766) |
| 0.1 | 0.5 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
| 0.1 | 0.5 | GO:0004920 | interleukin-10 receptor activity(GO:0004920) |
| 0.1 | 0.7 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
| 0.1 | 1.0 | GO:0000213 | tRNA-intron endonuclease activity(GO:0000213) |
| 0.1 | 0.7 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
| 0.1 | 0.6 | GO:0030235 | nitric-oxide synthase regulator activity(GO:0030235) TPR domain binding(GO:0030911) |
| 0.1 | 0.6 | GO:0019826 | oxygen sensor activity(GO:0019826) |
| 0.1 | 3.6 | GO:0030332 | cyclin binding(GO:0030332) |
| 0.1 | 0.5 | GO:0004530 | deoxyribonuclease I activity(GO:0004530) |
| 0.1 | 3.0 | GO:0015248 | sterol transporter activity(GO:0015248) |
| 0.1 | 2.2 | GO:0003756 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
| 0.1 | 1.2 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
| 0.1 | 1.3 | GO:0016641 | oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor(GO:0016641) |
| 0.1 | 1.6 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
| 0.1 | 0.5 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
| 0.1 | 1.0 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
| 0.1 | 1.0 | GO:0043422 | protein kinase B binding(GO:0043422) |
| 0.1 | 1.0 | GO:0046790 | virion binding(GO:0046790) |
| 0.1 | 0.9 | GO:0070324 | thyroid hormone binding(GO:0070324) |
| 0.1 | 1.1 | GO:0001851 | complement component C3b binding(GO:0001851) |
| 0.1 | 0.8 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
| 0.1 | 17.6 | GO:0050839 | cell adhesion molecule binding(GO:0050839) |
| 0.1 | 0.4 | GO:0004991 | parathyroid hormone receptor activity(GO:0004991) |
| 0.1 | 0.4 | GO:0097603 | temperature-gated ion channel activity(GO:0097603) |
| 0.1 | 0.3 | GO:0070259 | tyrosyl-DNA phosphodiesterase activity(GO:0070259) |
| 0.1 | 0.6 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
| 0.1 | 1.1 | GO:0003720 | telomerase activity(GO:0003720) RNA-directed DNA polymerase activity(GO:0003964) |
| 0.1 | 0.5 | GO:0060698 | endoribonuclease inhibitor activity(GO:0060698) |
| 0.1 | 0.4 | GO:0051033 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
| 0.1 | 2.0 | GO:0032452 | histone demethylase activity(GO:0032452) |
| 0.1 | 0.3 | GO:0005260 | channel-conductance-controlling ATPase activity(GO:0005260) |
| 0.1 | 0.4 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
| 0.1 | 0.8 | GO:0004565 | beta-galactosidase activity(GO:0004565) |
| 0.1 | 18.3 | GO:0005088 | Ras guanyl-nucleotide exchange factor activity(GO:0005088) |
| 0.1 | 2.1 | GO:0001972 | retinoic acid binding(GO:0001972) |
| 0.1 | 1.1 | GO:0003688 | DNA replication origin binding(GO:0003688) |
| 0.1 | 0.3 | GO:0070697 | activin receptor binding(GO:0070697) |
| 0.1 | 2.2 | GO:0008378 | galactosyltransferase activity(GO:0008378) |
| 0.1 | 1.4 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
| 0.1 | 1.9 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
| 0.1 | 0.4 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
| 0.1 | 0.4 | GO:0047374 | methylumbelliferyl-acetate deacetylase activity(GO:0047374) |
| 0.1 | 1.1 | GO:0015125 | bile acid transmembrane transporter activity(GO:0015125) |
| 0.1 | 1.4 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
| 0.1 | 0.7 | GO:0016174 | NAD(P)H oxidase activity(GO:0016174) |
| 0.1 | 0.7 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
| 0.1 | 0.2 | GO:0008511 | sodium:potassium:chloride symporter activity(GO:0008511) |
| 0.1 | 0.7 | GO:0042799 | histone methyltransferase activity (H4-K20 specific)(GO:0042799) |
| 0.1 | 0.9 | GO:0086056 | voltage-gated calcium channel activity involved in AV node cell action potential(GO:0086056) |
| 0.1 | 0.1 | GO:0030171 | voltage-gated proton channel activity(GO:0030171) |
| 0.1 | 5.3 | GO:0031490 | chromatin DNA binding(GO:0031490) |
| 0.1 | 0.2 | GO:0015140 | malate transmembrane transporter activity(GO:0015140) |
| 0.1 | 0.5 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
| 0.1 | 2.3 | GO:0001637 | G-protein coupled chemoattractant receptor activity(GO:0001637) chemokine receptor activity(GO:0004950) |
| 0.1 | 0.8 | GO:0048185 | activin binding(GO:0048185) |
| 0.1 | 1.6 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
| 0.1 | 0.5 | GO:0016423 | tRNA (guanine) methyltransferase activity(GO:0016423) |
| 0.1 | 0.5 | GO:0004046 | aminoacylase activity(GO:0004046) |
| 0.1 | 1.6 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
| 0.1 | 0.4 | GO:0019869 | chloride channel inhibitor activity(GO:0019869) |
| 0.1 | 1.0 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
| 0.1 | 0.7 | GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity(GO:0008353) |
| 0.1 | 0.6 | GO:0004321 | fatty-acyl-CoA synthase activity(GO:0004321) |
| 0.1 | 0.4 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
| 0.1 | 0.8 | GO:0004017 | adenylate kinase activity(GO:0004017) |
| 0.1 | 2.7 | GO:0000049 | tRNA binding(GO:0000049) |
| 0.1 | 2.0 | GO:0015295 | solute:proton symporter activity(GO:0015295) |
| 0.1 | 0.3 | GO:0016435 | rRNA (guanine) methyltransferase activity(GO:0016435) |
| 0.1 | 0.6 | GO:0004935 | adrenergic receptor activity(GO:0004935) |
| 0.1 | 0.1 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
| 0.1 | 0.2 | GO:0030337 | DNA polymerase processivity factor activity(GO:0030337) |
| 0.1 | 0.6 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
| 0.1 | 1.2 | GO:0005549 | odorant binding(GO:0005549) |
| 0.1 | 0.7 | GO:0015174 | basic amino acid transmembrane transporter activity(GO:0015174) |
| 0.1 | 1.2 | GO:0051721 | protein phosphatase 2A binding(GO:0051721) |
| 0.1 | 0.4 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
| 0.1 | 1.8 | GO:0051219 | phosphoprotein binding(GO:0051219) |
| 0.1 | 0.8 | GO:0004985 | opioid receptor activity(GO:0004985) |
| 0.1 | 0.2 | GO:0051431 | corticotropin-releasing hormone receptor 2 binding(GO:0051431) |
| 0.1 | 0.1 | GO:0008240 | tripeptidyl-peptidase activity(GO:0008240) |
| 0.0 | 0.1 | GO:0061628 | H3K27me3 modified histone binding(GO:0061628) |
| 0.0 | 1.6 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
| 0.0 | 0.2 | GO:0004966 | galanin receptor activity(GO:0004966) |
| 0.0 | 0.1 | GO:0034416 | bisphosphoglycerate phosphatase activity(GO:0034416) |
| 0.0 | 2.7 | GO:0001540 | beta-amyloid binding(GO:0001540) |
| 0.0 | 0.3 | GO:0051525 | NFAT protein binding(GO:0051525) |
| 0.0 | 0.5 | GO:0008175 | tRNA methyltransferase activity(GO:0008175) |
| 0.0 | 0.2 | GO:0051734 | ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity(GO:0046404) polydeoxyribonucleotide kinase activity(GO:0051733) ATP-dependent polynucleotide kinase activity(GO:0051734) |
| 0.0 | 0.1 | GO:0070984 | SET domain binding(GO:0070984) |
| 0.0 | 0.2 | GO:0043394 | proteoglycan binding(GO:0043394) |
| 0.0 | 1.0 | GO:0005521 | lamin binding(GO:0005521) |
| 0.0 | 0.3 | GO:0017040 | ceramidase activity(GO:0017040) |
| 0.0 | 0.2 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
| 0.0 | 0.2 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
| 0.0 | 4.0 | GO:0005085 | guanyl-nucleotide exchange factor activity(GO:0005085) |
| 0.0 | 0.7 | GO:0019789 | SUMO transferase activity(GO:0019789) |
| 0.0 | 2.9 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
| 0.0 | 0.2 | GO:0004419 | hydroxymethylglutaryl-CoA lyase activity(GO:0004419) |
| 0.0 | 1.1 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
| 0.0 | 0.3 | GO:0030492 | hemoglobin binding(GO:0030492) |
| 0.0 | 0.1 | GO:0046935 | 1-phosphatidylinositol-3-kinase regulator activity(GO:0046935) |
| 0.0 | 0.4 | GO:0005237 | inhibitory extracellular ligand-gated ion channel activity(GO:0005237) |
| 0.0 | 0.9 | GO:0015172 | L-glutamate transmembrane transporter activity(GO:0005313) acidic amino acid transmembrane transporter activity(GO:0015172) |
| 0.0 | 0.2 | GO:0004749 | ribose phosphate diphosphokinase activity(GO:0004749) |
| 0.0 | 3.3 | GO:0005496 | steroid binding(GO:0005496) |
| 0.0 | 0.7 | GO:0005328 | neurotransmitter:sodium symporter activity(GO:0005328) |
| 0.0 | 0.9 | GO:0043028 | cysteine-type endopeptidase regulator activity involved in apoptotic process(GO:0043028) |
| 0.0 | 0.3 | GO:0004738 | pyruvate dehydrogenase activity(GO:0004738) pyruvate dehydrogenase [NAD(P)+] activity(GO:0034603) pyruvate dehydrogenase (NAD+) activity(GO:0034604) |
| 0.0 | 0.2 | GO:0051575 | 5'-deoxyribose-5-phosphate lyase activity(GO:0051575) |
| 0.0 | 0.2 | GO:0030614 | oxidoreductase activity, acting on phosphorus or arsenic in donors(GO:0030613) oxidoreductase activity, acting on phosphorus or arsenic in donors, disulfide as acceptor(GO:0030614) glutathione dehydrogenase (ascorbate) activity(GO:0045174) methylarsonate reductase activity(GO:0050610) |
| 0.0 | 0.3 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
| 0.0 | 1.0 | GO:0001103 | RNA polymerase II repressing transcription factor binding(GO:0001103) |
| 0.0 | 0.5 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
| 0.0 | 0.4 | GO:0070182 | DNA polymerase binding(GO:0070182) |
| 0.0 | 0.4 | GO:0004526 | ribonuclease P activity(GO:0004526) |
| 0.0 | 0.2 | GO:1990932 | 5.8S rRNA binding(GO:1990932) |
| 0.0 | 0.7 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
| 0.0 | 0.1 | GO:0004001 | adenosine kinase activity(GO:0004001) |
| 0.0 | 0.6 | GO:0017070 | U6 snRNA binding(GO:0017070) |
| 0.0 | 0.2 | GO:0044548 | S100 protein binding(GO:0044548) |
| 0.0 | 0.3 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
| 0.0 | 0.3 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
| 0.0 | 0.4 | GO:0070001 | aspartic-type endopeptidase activity(GO:0004190) aspartic-type peptidase activity(GO:0070001) |
| 0.0 | 0.1 | GO:0061697 | protein-malonyllysine demalonylase activity(GO:0036054) protein-succinyllysine desuccinylase activity(GO:0036055) protein-glutaryllysine deglutarylase activity(GO:0061697) |
| 0.0 | 2.4 | GO:0004843 | thiol-dependent ubiquitin-specific protease activity(GO:0004843) |
| 0.0 | 0.1 | GO:0042301 | phosphate ion binding(GO:0042301) |
| 0.0 | 0.1 | GO:0099583 | neurotransmitter receptor activity involved in regulation of postsynaptic cytosolic calcium ion concentration(GO:0099583) |
| 0.0 | 0.1 | GO:0061575 | cyclin-dependent protein serine/threonine kinase activator activity(GO:0061575) |
| 0.0 | 0.1 | GO:0017134 | fibroblast growth factor binding(GO:0017134) |
| 0.0 | 0.9 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
| 0.0 | 0.7 | GO:0035255 | ionotropic glutamate receptor binding(GO:0035255) |
| 0.0 | 0.1 | GO:0003938 | IMP dehydrogenase activity(GO:0003938) |
| 0.0 | 0.2 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
| 0.0 | 0.7 | GO:0031624 | ubiquitin conjugating enzyme binding(GO:0031624) |
| 0.0 | 0.5 | GO:0017022 | myosin binding(GO:0017022) |
| 0.0 | 0.1 | GO:0034714 | type II transforming growth factor beta receptor binding(GO:0005114) type III transforming growth factor beta receptor binding(GO:0034714) |
| 0.0 | 0.1 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
| 0.0 | 0.1 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
| 0.0 | 0.0 | GO:0033842 | N-acetyl-beta-glucosaminyl-glycoprotein 4-beta-N-acetylgalactosaminyltransferase activity(GO:0033842) |
| 0.0 | 0.3 | GO:0031005 | filamin binding(GO:0031005) |
| 0.0 | 11.1 | GO:0005198 | structural molecule activity(GO:0005198) |
| 0.0 | 0.2 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
| 0.0 | 0.4 | GO:0070566 | adenylyltransferase activity(GO:0070566) |
| 0.0 | 0.1 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
| 0.0 | 0.4 | GO:0004298 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
| 0.0 | 0.1 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
| 0.0 | 0.2 | GO:0022829 | wide pore channel activity(GO:0022829) |
| 0.0 | 0.1 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
| 0.0 | 0.1 | GO:1990829 | C-rich single-stranded DNA binding(GO:1990829) |
| 0.0 | 0.1 | GO:0008821 | crossover junction endodeoxyribonuclease activity(GO:0008821) |
| 0.0 | 0.1 | GO:0010853 | cyclase activator activity(GO:0010853) guanylate cyclase activator activity(GO:0030250) |
Gene overrepresentation in curated gene sets: canonical pathways category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 2.0 | 38.8 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
| 1.5 | 59.8 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
| 0.9 | 37.0 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
| 0.8 | 31.3 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
| 0.6 | 22.5 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
| 0.5 | 38.9 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
| 0.5 | 14.2 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
| 0.5 | 2.9 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
| 0.5 | 3.7 | PID IL3 PATHWAY | IL3-mediated signaling events |
| 0.4 | 7.1 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
| 0.4 | 8.4 | PID S1P S1P1 PATHWAY | S1P1 pathway |
| 0.4 | 13.0 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
| 0.4 | 28.8 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
| 0.4 | 7.5 | PID ERBB1 DOWNSTREAM PATHWAY | ErbB1 downstream signaling |
| 0.4 | 22.2 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
| 0.4 | 3.9 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
| 0.4 | 15.8 | PID IL1 PATHWAY | IL1-mediated signaling events |
| 0.4 | 5.3 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
| 0.3 | 13.4 | ST P38 MAPK PATHWAY | p38 MAPK Pathway |
| 0.3 | 14.3 | PID INSULIN PATHWAY | Insulin Pathway |
| 0.3 | 0.6 | PID EPO PATHWAY | EPO signaling pathway |
| 0.3 | 23.6 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
| 0.2 | 9.1 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
| 0.2 | 4.2 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
| 0.2 | 8.5 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
| 0.2 | 7.7 | PID EPHA FWDPATHWAY | EPHA forward signaling |
| 0.2 | 2.7 | PID IL5 PATHWAY | IL5-mediated signaling events |
| 0.2 | 14.8 | SIG CHEMOTAXIS | Genes related to chemotaxis |
| 0.2 | 84.3 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
| 0.2 | 18.3 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
| 0.2 | 6.2 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
| 0.2 | 4.9 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
| 0.2 | 17.4 | PID NOTCH PATHWAY | Notch signaling pathway |
| 0.2 | 0.3 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
| 0.2 | 11.8 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
| 0.2 | 7.3 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
| 0.2 | 3.8 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
| 0.2 | 5.9 | PID ARF6 PATHWAY | Arf6 signaling events |
| 0.1 | 9.6 | PID LKB1 PATHWAY | LKB1 signaling events |
| 0.1 | 2.2 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
| 0.1 | 6.0 | PID MTOR 4PATHWAY | mTOR signaling pathway |
| 0.1 | 1.5 | PID IL2 1PATHWAY | IL2-mediated signaling events |
| 0.1 | 1.4 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
| 0.1 | 2.4 | ST GA12 PATHWAY | G alpha 12 Pathway |
| 0.1 | 4.3 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
| 0.1 | 0.3 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
| 0.1 | 0.7 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
| 0.1 | 5.9 | PID HEDGEHOG GLI PATHWAY | Hedgehog signaling events mediated by Gli proteins |
| 0.1 | 0.7 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
| 0.1 | 2.1 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
| 0.1 | 6.7 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
| 0.1 | 1.3 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
| 0.1 | 6.2 | PID P73PATHWAY | p73 transcription factor network |
| 0.1 | 1.9 | PID IL23 PATHWAY | IL23-mediated signaling events |
| 0.1 | 3.0 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
| 0.1 | 1.2 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
| 0.1 | 2.9 | PID FGF PATHWAY | FGF signaling pathway |
| 0.1 | 1.6 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
| 0.1 | 1.5 | SIG IL4RECEPTOR IN B LYPHOCYTES | Genes related to IL4 rceptor signaling in B lymphocytes |
| 0.1 | 1.1 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
| 0.1 | 1.1 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
| 0.1 | 5.6 | PID CDC42 PATHWAY | CDC42 signaling events |
| 0.1 | 0.5 | PID IL27 PATHWAY | IL27-mediated signaling events |
| 0.1 | 1.0 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
| 0.1 | 3.1 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
| 0.1 | 7.3 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
| 0.1 | 0.4 | PID CXCR4 PATHWAY | CXCR4-mediated signaling events |
| 0.1 | 0.4 | ST ADRENERGIC | Adrenergic Pathway |
| 0.1 | 2.0 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
| 0.1 | 0.8 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
| 0.0 | 0.7 | PID ERBB4 PATHWAY | ErbB4 signaling events |
| 0.0 | 0.7 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
| 0.0 | 1.2 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
| 0.0 | 0.5 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
| 0.0 | 0.4 | PID SHP2 PATHWAY | SHP2 signaling |
| 0.0 | 2.4 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
| 0.0 | 0.5 | PID TRAIL PATHWAY | TRAIL signaling pathway |
| 0.0 | 0.4 | PID BARD1 PATHWAY | BARD1 signaling events |
| 0.0 | 0.8 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
| 0.0 | 3.2 | PID E2F PATHWAY | E2F transcription factor network |
| 0.0 | 3.2 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
| 0.0 | 1.6 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
| 0.0 | 0.9 | PID IL12 2PATHWAY | IL12-mediated signaling events |
| 0.0 | 0.4 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
| 0.0 | 0.2 | SIG PIP3 SIGNALING IN CARDIAC MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
| 0.0 | 0.6 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
| 0.0 | 0.3 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
| 0.0 | 0.1 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
| 0.0 | 0.1 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
Gene overrepresentation in curated gene sets: REACTOME pathways category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 2.1 | 54.8 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
| 1.9 | 44.9 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
| 1.8 | 78.8 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
| 1.4 | 23.0 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
| 1.3 | 19.9 | REACTOME SIGNALING BY NOTCH4 | Genes involved in Signaling by NOTCH4 |
| 1.1 | 40.6 | REACTOME CELL CELL JUNCTION ORGANIZATION | Genes involved in Cell-cell junction organization |
| 0.9 | 0.9 | REACTOME ACYL CHAIN REMODELLING OF PS | Genes involved in Acyl chain remodelling of PS |
| 0.9 | 23.3 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
| 0.9 | 33.6 | REACTOME KINESINS | Genes involved in Kinesins |
| 0.9 | 7.7 | REACTOME PECAM1 INTERACTIONS | Genes involved in PECAM1 interactions |
| 0.8 | 22.9 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
| 0.8 | 5.1 | REACTOME FGFR2C LIGAND BINDING AND ACTIVATION | Genes involved in FGFR2c ligand binding and activation |
| 0.8 | 20.8 | REACTOME ACTIVATION OF RAC | Genes involved in Activation of Rac |
| 0.8 | 16.4 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
| 0.8 | 3.1 | REACTOME FGFR4 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR4 ligand binding and activation |
| 0.8 | 29.1 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
| 0.7 | 16.4 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
| 0.7 | 24.5 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
| 0.7 | 12.8 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
| 0.6 | 1.3 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
| 0.6 | 12.0 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
| 0.6 | 9.3 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
| 0.6 | 3.4 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
| 0.6 | 31.2 | REACTOME CELL JUNCTION ORGANIZATION | Genes involved in Cell junction organization |
| 0.5 | 25.8 | REACTOME AMINE COMPOUND SLC TRANSPORTERS | Genes involved in Amine compound SLC transporters |
| 0.5 | 10.5 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
| 0.5 | 8.2 | REACTOME TRAF3 DEPENDENT IRF ACTIVATION PATHWAY | Genes involved in TRAF3-dependent IRF activation pathway |
| 0.4 | 9.8 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
| 0.4 | 10.4 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
| 0.4 | 11.5 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
| 0.4 | 11.7 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
| 0.4 | 0.8 | REACTOME NUCLEOTIDE EXCISION REPAIR | Genes involved in Nucleotide Excision Repair |
| 0.4 | 7.9 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
| 0.4 | 12.4 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
| 0.4 | 10.6 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
| 0.4 | 8.2 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
| 0.4 | 13.8 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
| 0.3 | 14.9 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
| 0.3 | 36.8 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
| 0.3 | 3.6 | REACTOME SHC1 EVENTS IN ERBB4 SIGNALING | Genes involved in SHC1 events in ERBB4 signaling |
| 0.3 | 7.5 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
| 0.3 | 3.0 | REACTOME E2F ENABLED INHIBITION OF PRE REPLICATION COMPLEX FORMATION | Genes involved in E2F-enabled inhibition of pre-replication complex formation |
| 0.3 | 6.1 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
| 0.3 | 7.3 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
| 0.3 | 8.4 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
| 0.3 | 6.0 | REACTOME DOWNSTREAM TCR SIGNALING | Genes involved in Downstream TCR signaling |
| 0.3 | 6.4 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
| 0.3 | 6.9 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
| 0.3 | 0.5 | REACTOME ACYL CHAIN REMODELLING OF PI | Genes involved in Acyl chain remodelling of PI |
| 0.3 | 11.6 | REACTOME METABOLISM OF STEROID HORMONES AND VITAMINS A AND D | Genes involved in Metabolism of steroid hormones and vitamins A and D |
| 0.2 | 23.7 | REACTOME CELL SURFACE INTERACTIONS AT THE VASCULAR WALL | Genes involved in Cell surface interactions at the vascular wall |
| 0.2 | 21.8 | REACTOME L1CAM INTERACTIONS | Genes involved in L1CAM interactions |
| 0.2 | 14.0 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
| 0.2 | 0.9 | REACTOME PD1 SIGNALING | Genes involved in PD-1 signaling |
| 0.2 | 4.9 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
| 0.2 | 2.8 | REACTOME REVERSIBLE HYDRATION OF CARBON DIOXIDE | Genes involved in Reversible Hydration of Carbon Dioxide |
| 0.2 | 9.6 | REACTOME G1 PHASE | Genes involved in G1 Phase |
| 0.2 | 4.0 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
| 0.2 | 4.5 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
| 0.2 | 16.7 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
| 0.2 | 1.2 | REACTOME DEFENSINS | Genes involved in Defensins |
| 0.2 | 2.7 | REACTOME TRAFFICKING OF GLUR2 CONTAINING AMPA RECEPTORS | Genes involved in Trafficking of GluR2-containing AMPA receptors |
| 0.2 | 5.6 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
| 0.1 | 10.1 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
| 0.1 | 3.5 | REACTOME SIGNALING BY FGFR1 MUTANTS | Genes involved in Signaling by FGFR1 mutants |
| 0.1 | 3.7 | REACTOME ACYL CHAIN REMODELLING OF PC | Genes involved in Acyl chain remodelling of PC |
| 0.1 | 1.6 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
| 0.1 | 1.2 | REACTOME DESTABILIZATION OF MRNA BY KSRP | Genes involved in Destabilization of mRNA by KSRP |
| 0.1 | 1.0 | REACTOME DESTABILIZATION OF MRNA BY AUF1 HNRNP D0 | Genes involved in Destabilization of mRNA by AUF1 (hnRNP D0) |
| 0.1 | 1.0 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
| 0.1 | 1.5 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
| 0.1 | 3.7 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
| 0.1 | 4.9 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
| 0.1 | 7.9 | REACTOME PHASE1 FUNCTIONALIZATION OF COMPOUNDS | Genes involved in Phase 1 - Functionalization of compounds |
| 0.1 | 3.1 | REACTOME RNA POL I TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase I Transcription Termination |
| 0.1 | 0.9 | REACTOME PRE NOTCH TRANSCRIPTION AND TRANSLATION | Genes involved in Pre-NOTCH Transcription and Translation |
| 0.1 | 2.3 | REACTOME SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI | Genes involved in Synthesis of glycosylphosphatidylinositol (GPI) |
| 0.1 | 4.9 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
| 0.1 | 1.0 | REACTOME TETRAHYDROBIOPTERIN BH4 SYNTHESIS RECYCLING SALVAGE AND REGULATION | Genes involved in Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation |
| 0.1 | 2.7 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
| 0.1 | 2.6 | REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS | Genes involved in Regulation of gene expression in beta cells |
| 0.1 | 1.6 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
| 0.1 | 4.8 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
| 0.1 | 4.8 | REACTOME REGULATION OF WATER BALANCE BY RENAL AQUAPORINS | Genes involved in Regulation of Water Balance by Renal Aquaporins |
| 0.1 | 4.7 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
| 0.1 | 3.5 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
| 0.1 | 0.5 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
| 0.1 | 5.4 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
| 0.1 | 3.2 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
| 0.1 | 1.4 | REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
| 0.1 | 0.7 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
| 0.1 | 5.2 | REACTOME GLYCEROPHOSPHOLIPID BIOSYNTHESIS | Genes involved in Glycerophospholipid biosynthesis |
| 0.0 | 0.7 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
| 0.0 | 0.2 | REACTOME TRANSFERRIN ENDOCYTOSIS AND RECYCLING | Genes involved in Transferrin endocytosis and recycling |
| 0.0 | 1.0 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
| 0.0 | 0.7 | REACTOME RAS ACTIVATION UOPN CA2 INFUX THROUGH NMDA RECEPTOR | Genes involved in Ras activation uopn Ca2+ infux through NMDA receptor |
| 0.0 | 3.7 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
| 0.0 | 0.4 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
| 0.0 | 0.0 | REACTOME LIPOPROTEIN METABOLISM | Genes involved in Lipoprotein metabolism |
| 0.0 | 0.6 | REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
| 0.0 | 0.3 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
| 0.0 | 1.1 | REACTOME INCRETIN SYNTHESIS SECRETION AND INACTIVATION | Genes involved in Incretin Synthesis, Secretion, and Inactivation |
| 0.0 | 0.5 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
| 0.0 | 2.5 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
| 0.0 | 0.2 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
| 0.0 | 0.3 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
| 0.0 | 0.5 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
| 0.0 | 2.8 | REACTOME ACTIVATION OF THE MRNA UPON BINDING OF THE CAP BINDING COMPLEX AND EIFS AND SUBSEQUENT BINDING TO 43S | Genes involved in Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S |
| 0.0 | 1.1 | REACTOME EXTENSION OF TELOMERES | Genes involved in Extension of Telomeres |
| 0.0 | 0.9 | REACTOME FORMATION OF TUBULIN FOLDING INTERMEDIATES BY CCT TRIC | Genes involved in Formation of tubulin folding intermediates by CCT/TriC |
| 0.0 | 0.5 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
| 0.0 | 0.3 | REACTOME REGULATION OF MRNA STABILITY BY PROTEINS THAT BIND AU RICH ELEMENTS | Genes involved in Regulation of mRNA Stability by Proteins that Bind AU-rich Elements |
| 0.0 | 0.6 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
| 0.0 | 4.7 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
| 0.0 | 0.8 | REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
| 0.0 | 0.8 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
| 0.0 | 2.3 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
| 0.0 | 1.3 | REACTOME AMINO ACID AND OLIGOPEPTIDE SLC TRANSPORTERS | Genes involved in Amino acid and oligopeptide SLC transporters |
| 0.0 | 0.2 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
| 0.0 | 0.2 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
| 0.0 | 0.3 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
| 0.0 | 0.1 | REACTOME ADP SIGNALLING THROUGH P2RY12 | Genes involved in ADP signalling through P2Y purinoceptor 12 |
| 0.0 | 0.1 | REACTOME ERK MAPK TARGETS | Genes involved in ERK/MAPK targets |
| 0.0 | 0.3 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
| 0.0 | 0.3 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
| 0.0 | 0.2 | REACTOME ACTIVATION OF BH3 ONLY PROTEINS | Genes involved in Activation of BH3-only proteins |
| 0.0 | 0.1 | REACTOME REGULATION OF INSULIN SECRETION BY GLUCAGON LIKE PEPTIDE1 | Genes involved in Regulation of Insulin Secretion by Glucagon-like Peptide-1 |
| 0.0 | 1.8 | REACTOME OLFACTORY SIGNALING PATHWAY | Genes involved in Olfactory Signaling Pathway |
| 0.0 | 0.2 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
| 0.0 | 0.3 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |